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ABSTRACT
THE REGULATION OF RNA POLYMERASE I-MEDIATED TRANSCRIPTION IN
FOREBRAIN NEURONS
Scott Carl Smith
November 29,2011
Ribosomal biogenesis failure may contribute to neurodegenerative diseases, while
its excessive activation has been shown to drive tumor growth. As ribosomal production
is initiated and regulated by the Poll-mediated transcription of rRNA genes in the
nucleolus, the latter process had the attention of most researchers interested in the
dysregulation of ribosomal biogenesis in disease. When this work began, regulation of
Poll-mediated transcription in neurons had been poorly characterized. The goal of this
research has been to better define factors and signaling pathways that regulate neuronal
Poll activity. The first hypothesis tested was that DNA damage induced by a DNA
topoisomerase poison, etoposide, blocks neuronal Poll. Intracarotid delivery of
etoposide to adult rats resulted in Poll inhibition in the neocortex; however no apoptosis
was found. In neonate rats that received intracerebroventricular injections of etoposide
we observed inhibition of Poll in neurons in the neocortex and hippocampus. Neuronal
apoptosis was observed in these brain structures following etoposide treatment.
Therefore, these results confirm that neuronal Poll is sensitive to etoposide-induced
DNA damage and that such a sensitivity is present in both young and mature neurons of
whole rats. These results also demonstrate that Poll inhibition is distinct from the
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developmentally-restricted apoptotic response to etoposide. While working on these
studies, we made the surprising finding that doses of etoposide induced Poll-mediated
transcription in cultured cOJ1icai neurons and whole rat neonate brains. Thus, low doses
of etoposide that were 3 orders of magnitude lower than those inducing Poll block
apoptosis and were sufficient to activate Poll and the DNA double strand break response,
including autophosphorylation of the DNA damage signaling kinase Ataxia-telangiectasia
Mutated (ATM). Therefore, it was hypothesized that ATM activated neuronal Poll.
Indeed, pharmacological inhibition of ATM with KU55933 blocked Poll activation in
response to low concentrations of etoposide or to another topoisomerase-II inhibitor,
ICRF-193. Basal levels of nucleolar transcription were also suppressed. Moreover, Polldriven transcription was reduced in the cerebellum of 5-week old ATM-null mice.
Additionally, pharmacological inhibition of ATM reduced neuronal Poll activation in
response to the neurotrophin, BDNF, or to increased synaptic activity. Consistent with
the notion that BDNF-mediated neurite outgrowth requires Poll, KU55933 appeared to
reduce BDNF-mediated neurite outgrowth. Similar effects on ribosomal biogenesis and
neuronal growth were observed with a pharmacological inhibitor of the ATM-related
kinase mTOR. Finally, ATM inhibition reduced Poll activation in serum-stimulated
human cell lines. These findings identified A TM as a novel regulator of Poll. They
further confirmed that in neurons, as in non-neuronal cells, mTOR also regulates Poll.
My results suggest that at least some consequences of ATM deficiency in humans,
including neurodegeneration or impaired proliferation, result from insufficient ribosomal
biogenesis.
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Taken together, these studies filled important gaps in the knowledge of Poll
regulation in neurons by demonstrating nucleolar transcription sensitivity to DNA
damage in whole animal brains and by defining signaling pathways contributing to its
activation by neurotrophic stimulation. My findings suggest that DNA damage or loss of
TM may contribute to neurodegeneration by decreasing ribosomal biogenesis.
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CHAPTER I
INTRODUCTION
First described in neurons in 1839 by a pupil of Jan Evangelista Purkinje, Gabriel
Valentin (Harris, 2000), the primary function of the nucleolus was only definitively
agreed upon in 1965 (Pederson and Tsai, 2009). Within the nucleus, Valentin described a
"sharply rounded object which thus constitutes a kind of nucleus within a nucleus."
Indeed, the definition of the word, "nucleolus" is nucleus within a nucleus. Nucleolar
function, identified primarily in transfonned cells, was the place of ribosomal biogenesis
(Pederson and Tsai, 2009). Though key findings in the mid 1960's led many researchers
to agree upon nucleolar function, it took a meeting in Uraguay by groups of scientists
who had watched the development of nucleolar function to officially claim ribosomal
biogenesis to the location of the nucleolus (Pederson and Tsai, 2009). In recent years with
the development of advanced proteomics tools it was identified that only approximately
30% of the more than 4500 proteins residing in the nucleolus are directly associated with
ribosomal biogenesis. This has been interpreted to mean that though ribosomal
biogenesis is a function of the nucleolus, it is not the only function. The plurifunctional
nucleolus is regularly revealing new and exciting functions to the scientists who study it
nearly 200 years after its description in animal cells was first published.
Despite being the first described animal cell with a nucleolus, the nucleolus of the
postmitotic neuron has gained attention only recently. The cellular function of neuronal
nucleoli, the regulation of Poll transcription and the responsiveness to stress are all

present in neurons as well as cycling cells; yet the fates of neurons are different from
cycling cells. Only a small percentage of the total neuronal population of the brain
regenerate, thus the longevity of neurons is of the utmost importance in healthy
development and aging. Further, in neurons actively translating ribosomes are present in
the soma, axons and dendrites of neurons. The functions of proteins being synthesized
locally include axon guidance (Campbell and Holt, 2001), synapse formation (Schacher
and Wu, 2002), neuronal survival (Howe and Mobley, 2005; Cox et aI., 2008), and
synaptic plasticity (Ostroff et aI., 2002). Indeed, bidirectional transport of locally
translated proteins is a means of signaling the great distance between the soma and
synapse (Howe and Mobley, 2005; Cox et aI., 2008; Lin and Holt, 2008). In addition,
morphogenesis ofneurites requires transcription leading to ribosomal biogenesis (Gomes
et aI., 2011). Therefore the ongoing synthesis of ribosomes, the half-life of which is 7-15
days (Stoykova et aI., 1983), is of utmost importance in neurons. The generation of new
ribosomes may be important in maintaining neuronal function as the accumulation of
oxidative damage has been identified in RNA of ribosomes of Alzheimer's disease
patients (Honda et aI., 2005; Ding et aI., 2006). Most steps of ribosome synthesis occur
in the nucleolus, a transcription-dependent nuclear structure.
Nucleolar transcription of rRNA genes initiates ribosomal biogenesis and is
tightly regulated to adjust the rate of ribosomal production to cellular needs. Pathways
that signal cellular growth, such as mammalian target of rapamycin (mTOR), mitogenactivated protein kinases (MAPK), extracellular signal-related kinase (ERK) and p90
ribosomal S6 kinase (RSK), and cyclin-dependent kinases (CDKs) directly regulate the
nucleolus (Grummt, 2003; Rubbi and Milner, 2003; Mayer et aI., 2005; Mayer and
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Grummt, 2005; Boulon et aI., 2010; Drygin et aI., 2010; Hetman et aI., 2010). Nucleolar
transcription is also affected by cellular stress. Nucleolar transcription is inhibited by
DNA damage, reactive oxygen species or nutrient starvation (Rubbi and Milner, 2003;
Mayer et aI., 2005; Mayer and Grummt, 2005; Kruhlak et aI., 2007; Kalita et aI., 2008).
The nucleolar sensitivity to stress provides a convenient stress signaling mechanism.
Stress-induced inhibition of ribosomal biogenesis preserves cellular energy (Grummt and
Voit, 2010) and disrupts nucleolar integrity thereby allowing the passive diffusion of
nucleolar-residing proteins that can mediate various stress responses throughout a cell,
such as stabilization ofp53 (Rubbi and Milner, 2003; Andersen et aI., 2005; Mayer and
Grummt, 2005). However, long-term reduction of ribosomal biogenesis may have
permanent negative consequences on the cell. The pathology of ribosomopathies, whose
origins are in decreased ribosomal biogenesis, provides evidence for this notion (Lipton
and Ellis, 2009; Burwick et aI., 2011). In neurons, nucleolar transcription is necessary
for neuronal development and maintenance (Parlato et aI., 2008).
The present studies began as an attempt to identify DNA damaging agents that
affected Poll transcriptional activity in neurons. With such tools, we planned to test
whether DNA damage-induced nucleolar disruption occurs in both developing and
mature brain. While conducting these studies we made a surprising discovery that a
DNA damage signaling protein kinase, Ataxia-telangiectasia mutated (ATM) stimulates
nucleolar transcription. Therefore, we discovered a novel regulator of nucleolar
transcription that functions independently of canonical Poll-mediated regulatory
signaling pathways.
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The nucleolus and transcription of ribosomal RNA genes

The nucleus is an organelle that encompasses non-membrane-bound structures,
such as Cajal bodies, PML bodies, and others, all of which represent functional
compartmentalization (Emmott and Hiscox, 2009). Biogenesis of the nucleolus is
transcription dependent (Rubbi and Milner, 2003). The nucleolus contains a vast
proteome as well as nucleic acids with a particular enrichment in RNA (Boisvert et aI.,
2007). Though once believed to be only a constitutive ribosome producer, the nucleolus
is now known to be a highly dynamic compartment. It is responsive to growth stimuli
(Grummt, 2003) and stress signals (Mayer et aI., 2005), and is involved in such diverse
functions as DNA repair (Boisvert et aI., 2007), stress sensing (Mayer and Grummt,
2005), RNA splicing and processing (Tschochner and Hurt, 2003; Andersen et aI., 2005;
Wahl et aI., 2009).
RNA Polymerase-l (Poll) is the nucleolar RNA polymerase which is the only
mediator of nucleolar transcription of the repeated nucleolar genes encoding 18S, 28S
and 5.8S rRNAs (ribosomal DNA, rDNA). Each of several hundred nucleolar rDNA
units can be transcribed into a 45S precursor-rRNA (pre-rRNA), which is rapidly
processed to the 18S, 28S, and 5.8S transcripts (Fig.!). Human rRNA genes are
organized in tandem repeats at nucleolar organizer regions (NORs) on the p12 band of
the acrocentric chromosomes (13, 14, 15,21, and 22) (Grummt, 2003; Mais et aI., 2005;
Drygin et aI., 2010). Ribosomal biogenesis begins with the transcription ofrDNA by
Poll at NORs in the fibrillar center (FC) of the nucleolus. The processing of pre-rRNA is
accomplished by small nucleolar ribonucleoproteins (snoRNPs) in the dense fibrillar
component (DFC) of the nucleolus, just exterior to the FC (Boisvert et aI., 2007). The
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final maturation of ribosomal transcripts and assembly with ribosomal proteins occurs in
the granular component (GC) of the nucleolus, the region furthest from the Fe and
closest to the nucleoplasm. The 5S rRNA transcript, transcribed by RNA Polymerase-III
outside the nucleolus, assembles with the 28S and 5.8S rRNA transcripts and ribosomal
proteins to form the 60S subunit (Boisvert et aI., 2007; Strunk et aI., 2011). The mature
18S rRNA transcript assembles with ribosomal proteins to form the 40S subunit. The
40S and 60S subunits are individually exported to the nucleoplasm and subsequently
assembled together to form the mature ribosome (Boisvert et aI., 2007).
Ribosomal biogenesis is extremely costly to the cell (Warner, 1999). In
Scerevisiae approximately 2000 ribosomes are generated per minute. The toll this takes
on the cell accounts for 60% of the total cellular transcriptional output, and is the sum of
no less than 50% of RNA Polymerase II-mediated transcription. PolII is required to
transcribe 137 mRNAs, accounting for 78 ribosomal proteins that are directly involved in
ribosomal biogenesis. Indeed, enzymes such as kinases that regulate ribosomal
biogenesis are not even accounted for in these calculations (Warner, 1999).
Synthesis ofrRNA is highly regulated as would be expected for such an energyrequiring process. Ribosomal biogenesis requires the cooperation and activation of
multiple co-factors (Fig.2). Pre-initiation complex assembly requires the recruitment of
upstream binding factor (UBF) and transcription initiation factor - IB (rodent)/promoter
selectivity factor (humans) (TIF-IB/SLl) (Drygin et aI., 2010). DNA binding by the UBF
high mobility group (HMG) box allows the bending of approximately 140 base pairs (bp)
which creates an enhancosome structure to promote transcription (Bazett-Jones et aI.,
1994). The UBF-mediated enhancosome structure stabilizes TF-IB/SLl promoter binding
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and recruits Poll (Drygin et aI., 2010). UBF also engages in the promotion of
transcriptional elongation. The assembly of a productive transcription initiation complex
depends on Poll recruitment. TIF-IB, made up of the TATA binding protein and TATA
binding protein-associated factors, TAF 1 proteins, recruits Poll. The interaction between
TAFls ofTIF-IB/SLl and TIF-IA creates a bridge between TIF-IB/SLl and RPA43, a
subunit of Poll (Grummt, 2003; Drygin et aI., 2010).
Epigenetic modification of rDNA can also enhance or repress nucleolar
transcription. Though not as rapid as the transcriptional regulation of active rDNA by
signaling pathways, epigenetic modification can regulate the transcriptional output of the
nucleolus by recruiting silenced rDNA to an active state or vice versa (Grummt and
Ladumer, 2008). Importantly, epigenetic modification of rDNA can be mediated by cellextrinsic factors that are critical to cell growth, such as glucose levels (Murayama et aI.,
2008). Promoters of silenced rRNA genes are hypermethylated at CpG residues. The
nucleolar remodeling complex (NoRC) silences rDNA by recruiting DNA
methyltransferase and histone deacetylase activity to the promoter (McStay and Grummt,
2008).
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Figure 1

Ribosomal DNA repeats

Pol1

•••••m•••••••

Ribosomal DNA gene
45S rRNA precursor

1

rapid rRNA processing

--_/
5.8S

Figure 1: The nucleolus is a transcription-mediated organelle.
Ribosomal DNA (rDNA) is organized in tandem repeats in nucleolus. Transcription ofrDNA is
conducted by RNA Polymerase I , which produces the 45S precursor rRNA (pre-rRNA or 45S
rRNA). Rapid processing of rRNA results in the mature I8S, 5.8S and 28S transcripts.
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Figure 2

Figure 2. A diagram of the transcription initiation unit as described in the text.
A productive transcription initiation complex requires the UBF - TIF -1 B/SL 1 stabilization on the
promoter, leading to the recruitment of Poll . Interaction between TIF -1 B and Poll is mediated
by TIF-lA.

Role of the nucleolus in cell growth
During neuronal development, establishing connections of individual neurons to
one another is dependent upon extracellular signals, such as growth factors, electrical
activity and neurotransmitters. Local protein synthesis is often required to respond to
many such signals (Alvarez et aI., 2000; Ethell and Pasquale, 2005; Howe and Mobley,
2005 ; Matus, 2005; Lin and Holt, 2008; Gumy et aI. , 2010; Jan and Jan, 2010; Mikl et aI. ,
2010; Neal et aI., 2010; Gutierrez and Davies, 2011). The response to these signals results
in the activation of intracellular signaling cascades that stimulate neurite outgrowth and
synaptogenesis (Miller and Kaplan, 2003). Thus, as an initiator of ribosomal biogenesis,
nucleolar transcription is critical for cellular growth. An important mediator for such
regulation is TIF-l A with a variety of signaling pathways that converge on it (Grummt,
2003). mTOR regulation of Poll-mediated transcription is accomplished through
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phosphorylation ofTIF-IA. mTOR promotes the activation of Poll-mediated
transcription by phosphorylating S44 and inhibits Poll transcription by phosphorylating
S199 (Mayer et aI., 2004). ERK1I2 regulation ofTIF-IA potentiation occurs with the
cooperation ofp90 ribosomal S6 kinase (RSK). Mitogen stimulation occurs through
receptor tyrosine kinase (RTK) and the signaling cascade follows through RAS, RAF,
MEK and finally to ERK1I2. ERK1I2 then activates RSK, which phosphorylates TIF-IA
at S649. That is followed by ERK1I2-mediated phosphorylation ofTIF-IA at S633.
Both phosphorylations are required for ERK1I2-mediated TIF-IA activity.
Brain-derived neurotrophic factor (BDNF) is a major neurite outgrowthpromoting neurotrophin for forebrain neurons. BDNF binds TrkB receptors that signal to
TIF-IA via RAS and ERK1I2 pathways to regulate neurite outgrowth and induce primary
dendrite formation through the activation of MAP kinase and PI3K signaling pathways
(Dijkhuizen and Ghosh, 2005). BDNF-mediated outgrowth of neurites has recently been
shown to be TIF-IA-dependent via ERK1I2 signaling (Gomes et aI., 2011). In that study,
the constitutive activation ofMKKI induced neurite outgrowth similar to BDNF-induced
outgrowth in a TIF-IA-dependent manner. Similarly, constitutively active TIF-IA also
induced neurite outgrowth. Indeed, such findings suggest that Poll is a critical progrowth target ofERK1I2 (Gomes et aI., 2011).
mTOR signaling that is activated by insulin and neurotrophins through RASdependent activation of Phosphatidyl inositol 3-kinase (PI3K) also contributes to neurite
outgrowth and branching. While its role in promoting neurite outgrowth has been
attributed to its effect on translation (Jaworski et aI., 2005; Swiech et aI., 2008), mTOR is
also a major regulator of Poll and ribosomal biogenesis by targeting TIFIA (Grummt,
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2003; Drygin et aI., 2010). However, whether that Poll-driven activity ofmTOR is
essential for neurite outgrowth remains to be determined.
In addition to TIFIA, other initiation complex co-factors are regulated by growth
promoting signaling pathways. UBF phosphorylation by ERKl/2 in response to
mitogenic signals at Tll7 and T201 robustly modifies the DNA architecture of the
enhancosome to promote Poll transcription through it (Stefanovsky et aI., 2001;
Stefanovsky et aI., 2006). mTOR phosphorylates UBF at its C-terminus thereby
promoting the interaction between UBF and TIF-IB/SLl in response to growth signals
and nutrients (Hannan et aI., 2003). In proliferating cells, cyclins and their kinases
activate UBF during cell cycle progression. Cyclin E/Cdk2 and Cyclin AlCdkl
phosphorylate UBF during interphase on S484 by Cyclin D/Cdk4 and Cyclin E/Cdk2 and
on S388 (Drygin et aI., 2010 86).

Nucleolar roles beyond ribosomal biogenesis
A vast proteome in the nucleolus has been identified suggesting that the
functional significance of the nucleolus goes beyond ribosomal biogenesis (Andersen et
aI., 2005). Annotations of nucleolar proteins have implicated the nucleolus in processes
such as apoptosis, cell stress signaling, DNA repair, signal recognition particle
biosynthesis, telomere function, aging, and synaptic activity, among others (Pederson,
1998; Mayer and Grummt, 2005; Jordan et aI., 2007). Proteins directly related to
ribosomal biogenesis account for only 30% of the nucleolar proteome (Andersen et aI.,
2005; Boulon et aI., 2010). Proteins can freely diffuse in and out of the nucleolus since
there is no membrane boundary, therefore the retention of many proteins to the nucleolus
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depends on the affinity to bind relatively immobile components of that structure
(Pederson and Tsai, 2009). Conversely, upon inhibition of Poll, many nucleolar proteins
diffuse throughout the nucleoplasm and/or the cytosol. One such protein,
NucleophosminIB23, is a multi-functional histone chaperone protein (den Besten et aI.,
2005; Maggi et aI., 2008; Nalabothula et aI., 2010; Colombo et aI., 2011). It is required
for the correct assembly and disassembly of nucleosomes (Maggi et aI., 2008; Colombo
et aI., 2011), participates in shuttling pre-ribosome particles from their point of synthesis
to the cytoplasm (den Besten et aI., 2005), and after its nucleolar release following Poll
inhibition, is involved in cell cycle arrest (Nalabothula et aI., 2010) and p19 ARF
stabilization (Colombo et aI., 2011).

The nucleolus as a stress sensor
rDNA transcription is highly sensitive to stress including exogenous DNA
damage, oxidants, hypoxia, heat shock (Rubbi and Milner, 2003), or nutrient starvation
(Mayer et aI., 2004). The mechanisms associated with the suppression of rDNA
transcription have been investigated only recently (Boulon et aI., 20 I 0). Following
nutrient starvation, increasing AMP/ATP ratio activates a protein kinase AMPK, which
carries out inhibitory phosphorylation ofTIFIA at S635 (Grummt, 2003; Hoppe et aI.,
2009). In response to exogenous oxidative stress, nucleolar transcription suppression is
dependent upon c-jun N-terminal protein kinase 2 (JNK2) (Mayer et aI., 2005) that also
targets TIF 1A. Similarly, Poll-mediated transcriptional inhibition following irradiation
or etoposide has been shown to be ATM-dependent (Kruhlak et aI., 2007).
As the nucleolus is a transcription-dependent structure, inhibition of Poll disrupts
nucleolar integrity (Olson, 2004; Boulon et aI., 2010). The disrupted nucleolar integrity
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has been characterized ultrastructurally as the separation of the FC and Gc. In addition,
many nucleolar proteins are released from the nucleolus critically contributing to the
stress responses such as p53-mediated apoptosis (Boulon et ai., 2010). Under basal
conditions p53 is continuously ubiquitinated by the E3 ligase, MDM2, and thereafter
degraded in the cytoplasm. Upon nucleolar disruption, ARF is released to the
nucleoplasm where it binds up MDM2 thereby preventing its association with p53. This
allows p53 to accumulate in the nucleus and be a responsive genotoxic effector (Rubbi
and Milner, 2003). Nucleophosmin also binds ARF thereby preventing its association
with E3 ligases (Colombo et ai., 2011). In addition, ribosomal proteins L5, LIl, L23 and
S7 have been shown to directly associate with MDM2 to prevent p53 degradation. Such
interactions are promoted by nucleolar disruption (Boulonet ai., 2010). Alternatively,
increased translation ofLl1 can promote p53 accumulation even if nucleolar structure is
undisturbed. LIl mRNA contains a 5' -terminal oligopyrimidine sequence that allows
translation of a subset of mRNAs under global translation inhibition. Indeed, 40S
ribosomal subunit biogenesis inhibition drove LII mRNA translation leading to p53
acetylation in the absence of nucleolar disruption (Fumagalli et ai., 2009; Boulon et ai.,
2010). Post-translational modifications ofp53 can promote its accumulation following
stress. For instance, acetylation ofp53 and MDM2 by p300/CBP prevents their binding
following nucleolar stress. Under non-stress conditions, however, MDM2 suppresses
p53 acetylation (Boulon et ai., 2010).
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Neurodegenerative disease and impaired nucleolar transcription
Chronically impaired nucleolar transcription has negative consequences on nonproliferating cells (Kalita et aI., 2008; Parlato et aI., 2008; Hetman et aI., 2010; Rieker et
aI., 2011). Impaired nucleolar transcription by the genotoxin, camptothecin, or the small
hairpin RNA knockdown of the nucleolar transcription co-factor, Tif-la, causes neuronal
nucleolar disruption and apoptotic cell death in cultured cortical neurons from newborn
rats (Kalita et aI., 2008). Similarly, ablation of Tif-la in the developing CNS causes
massive apoptosis of neuronal precursors that prevents brain development (Parlato et aI.,
2008). In both dissociated neurons and in the whole animal, the accumulation ofp53 in
neurons is a trigger for relatively rapid apoptotic death upon Poll inhibition. Conversely,
if Tif-la is eliminated from the mature nervous system, slow-progressing
neurodegeneration occurs. The first evidence becomes noticeable one month following
the induced knock out of the Tif-l a gene and continues for at least 30 weeks, at which
time 80% of neurons are lost (Parlato et aI., 2008). This is consistent with the long halflife of neuronal ribosomes (Stoykova et aI., 1983). Impaired nucleolar transcription
likely hinders ribosome production and renewal leading to ribosomal failure, insufficient
protein synthesis and subsequent neuronal atrophy (Hetman & Pietrzak, 2011, in press).
In addition, the disruption of nucleolar integrity may allow the diffusion of nucleolar
proteins into the nucleoplasm that have chronic negative effects on the cell, such as the
accumulation ofp53 (Emmott and Hiscox, 2009) (Fig. 3).
Evidence of accumulated oxidative stress is prevalent in many neurodegenerative
diseases (Zhang et aI., 1999; Sayre et aI., 2001; Ding et aI., 2005; Honda et aI., 2005;
Barber et aI., 2006; Ding et aI., 2006; Markesbery and Lovell, 2006; Brooks, 2007; Fishel
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et ai., 2007; Lovell and Markesbery, 2007b; Martin, 2008b; Nunomura et aI., 2009;
Kirshner et ai., 2011). Indeed, in PD and AD, there is evidence that RNA oxidation
occurs in the cytoplasm and affects ribosomes (Zhang et aI., 1999; Ding et aI., 2005;
Honda et aI., 2005; Ding et aI., 2006; Nunomura et ai., 2009): In AD, this has caused
ribosomes to have reduced protein translation efficiency thereby preventing sufficient
cellular maintenance and contributing to the vicious cycle of AD pathology (Ding et aI.,
2005). Conversely, increased susceptibility to oxidative stress may stem from impaired
nucleolar transcription (Rieker et aI., 2011).
The ablation of Tif-la specifically in developing dopaminergic neurons also
causes a substantial reduction in tyrosine hydroxylase-positive neurons from the
substantia nigra and striatum only 15 days after birth. At postnatal day 30 there were
significant locomotor deficits associated with ablation of Tif-I a in dopaminergic neurons
(Rieker et aI., 2011). As may be expected, ablation of Tif-I a in mature dopaminergic
neurons using a tamoxifen-inducible Cre-recombinase caused a reduction in
dopaminergic neurons as early as seven weeks following initial tamoxifen injections,
reduced dopamine content of dopaminergic neurons, and within 12 weeks produced
locomotor deficits (Rieker et aI., 2011). These results point to the necessity of Pollmediated transcription for dopaminergic neuronal maintenance, suggesting a possible
relationship between nucleolar insufficiency and PD. In fact, disrupted nucleoli in
dopaminergic nigral neurons have been documented in postmortem brain samples from
PD patients (Rieker et aI., 2011).
Excessive epigenetic silencing ofrDNA has also been linked to the hippocampal
atrophy in severe depression of developmental origin and AD. Hypermethylation of

14

rDNA promoter CpGs was observed in the postmortem hippocampus of suicide victims
with depression and a history of childhood abuse (McGowan et aI. , 2008). Similar
hypermethylation has been documented in the cerebral cortex of AD patients and in the
elderly with mild cognitive impairment, which often represents early stage AD (Pietrzak
et aI., 2011a). These findings may suggest active rDNA silencing mediated by cellular
stress over many years.

Figure 3
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Figure 3: Potential consequences of nucleolar insufficiency.
Long-lasting nucleolar transcriptional impairment may prevent the sufficient renewal of
ribosomes that are readily oxidized loosing their translational activity (Hetman &
Pietrzak, submitted). That may lead to ribosomal failure and reduction in protein
synthesis (Honda et aI. , 2005 ; Ding et aI. , 2006). In addition, the diffusion of nucleolusresiding stress response proteins into the nucleoplasm/cytoplasm may trigger chronic
activation of stress signaling including accumulation ofp53 (Rubbi and Milner, 2003 ;
Emmott and Hiscox, 2009; Boulon et aI. , 2010).
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DNA damage and repair in the nervous system
Age-related onset ofneurodegeneration is likely in part a function of the neuronal
accumulation ofunrepaired DNA damage (Rutten et aI., 2003; Barber et aI., 2006;
Culmsee and Landshamer, 2006; Dolle et aI., 2006; Droge and Schipper, 2007; Loerch et
aI., 2008; Martin, 2008a; McKinnon, 2009). Increased oxidative damage to cell
membranes, proteins and nucleic acids, including DNA, has been demonstrated in the
most prevalent of the adult-onset neurodegenerative diseases such as Alzheimer's disease
(AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) (Ferrante et aI.,
1997; Gabbita et aI., 1998; Zhang et aI., 1999; Dizdaroglu et aI., 2002; Lovell and
Markesbery, 2007a, b).
Due to its high oxygen consumption rate (approximately 20% of consumed
oxygen), the brain has an increased susceptibility to oxidative damage compared with
other organs. This damage is generated by reactive oxygen species (ROS) derived
primarily from the process of oxidative phosphorylation (Lovell and Markesbery, 2007b).
Oxidative reactivity to DNA results in the creation of numerous oxidized base adducts,
the most prominent of which is 8-hydroxyguanine (8-0HG). ROS can also cause strand
breaks and DNA cross links with DNA and proteins (Ferrante et aI., 1997; Dizdaroglu et
aI., 2002). Studies of post-mortem AD patients have identified increased 8-0HG levels
in mitochondrial DNA (mtDNA) in the parietal lobe (Mecocci et aI., 1993), and in
nuclear DNA (nDNA) from the temporal and parietal lobes (Gabbita et aI., 1998).
Evidence that such DNA damage triggered DNA damage response has been
shown in human diseases and/or animal models of the disease. The accumulation ofp53
and presence of activated caspase 3 has been demonstrated in human post-mortem brains

16

of AD patients, as well as in the brains of transgenic mice overexpressing Ap. Similarly,
oxidative insult resulted in p53-dependent apoptosis in the substantia nigra of mice
rendered parkinsonian by I-methyl-4-phenyl-l,2,3,6-tetrahydropyridine- (MPTP).
Though many studies have demonstrated that cell loss is prominent in the AD, PD, and
ALS post-mortem human central nervous system (CNS) (Honig and Rosenberg, 2000),
the mechanisms of degenerative changes at the early-stages of these conditions are
unknown (Droge and Schipper, 2007). Indeed, apoptosis following DNA damage has
been demonstrated in developing neurons and in whole animals, but is attenuated in
mature neurons (Lesuisse and Martin, 2002; Martin, 2008a; McKinnon, 2009).
Neurons can accumulate various forms of DNA damage. The repair of oxidative
lesions can lead to the release of free bases, or apurinic/apyrimidinic sites (AP). The
presence of a lost purine or pyrimidine and the deoxyribose with a cut in the
phosphodiester backbone of one strand is a single strand break (SSB), which may also be
formed by X-rays, and topoisomerase I inhibiting chemotherapy agents, such as
camptothecin (CPT) (Morris and Geller, 1996; McMurray, 2005). Chemical agents, such
as the commonly used chemotherapy agents, etoposide and cisplatin, and gammairradiation may induce chemical cross-linking of two complementary DNA strands,
termed interstrand cross-links (ICLs) and cuts in both strands, termed double strand
breaks (DSBs).
Genotoxic lesion repair in post-mitotic neurons employs similar machinery as in
other cells. The frequency of genotoxic lesions mediates the activity prominence of the
repair pathway. Base excision repair (BER) is the primary repair pathway (Fishel et aI.,
2007), followed by, nucleotide excision repair (NER) and non-homologous end joining
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(NHEJ). Homologous recombination (HR) is believed to be relatively inactive in
neurons (McMurray, 2005; Fishel et aI., 2007; Lee and McKinnon, 2007). DSB are
repaired by NHEJ and HR pathways (McKinnon, 2009). HR is functional only in
proliferating cells, whereas NHEJ is active in proliferating and differentiating cells, such
as in the mature nervous system. DSB detection is conducted by ataxia telangiectasia,
mutated (ATM), ataxia telangiectasia and RAD3-related (ATR), or DNA-dependent
protein kinase (DNA-PK) (Hoeijmakers, 2001; McKinnon, 2009). NHEJ is not error-free
and proceeds with the recruitment of the subunits ofDNA-PK, KU70 and KU86 to the
open ends of DNA, which recruits the catalytic subunit of DNA-dependent protein kinase
(DNA-PKcs). Without a template to synthesize from, the two broken ends are linked
together by ligase 4 (LIG4), which may result in the gain or loss of nucleotides
(Hoeijmakers, 2001; McKinnon, 2009).
The signaling of strand breaks involves DNA damage signaling kinases, including
poly(ADP-ribose) polymerase I (PARP), ATM, ATR and DNA-PK (Hoeijmakers, 2001;
Caldecott, 2008; McKinnon, 2009). ATM is activated by autophosphorylation via
interaction with Nijmegen breakage syndrome 1 (NBSl) and the remaining members of
the MRN complex (component proteins, MREll, RAD50) (Goodarzi et aI., 2004; Lavin,
2004; Iijima et aI., 2008; Morio and Kim, 2008). ATM substrates for a cell salvaging
pathway include those responsible for arresting cell cycle and commencing repair
(including CHK2 and DNA-PK), whereas substrates of the suicide pathway include p53,
caspase 3 and PUMA (Hoeijmakers, 2001; Lee and McKinnon, 2007; Morio and Kim,
2008; McKinnon, 2009). The inhibition of DNA topoisomerases has been shown to
activate the DNA damage signaling kinases. Topoisomerase inhibitors, etoposide
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(topoisomerase II) (Kruman et aI., 2004; Besirli and Johnson, 2006) and camptothecin
(topoisomerase I) (Sordet et aI., 2009), activate ATM in post-mitotic neurons. The latter
study demonstrated this finding in a manner independent ofDNA-PK.

Topoisomerases and their chemical inhibitors
The topoisomerases (I and II) catalyze DNA topology rearrangement to maintain its
energetically stable forms from the relaxed or super-coiled DNA forms (Sharma and
Mondragon, 1995; Bates and Maxwell, 1997). Topoisomerase I regulates DNA topology
by cleaving one strand of DNA and creating a covalent 3' -phosphotyrosine bond at its
catalytic center (Pommier, 2009). Mammals have two topoisomerase II isoforms, a and

p. Topoisomerase lIa is present in proliferating tissues, while IIp is abundant in
terminally differentiated cells (Nur et aI., 2007). It is particularly important in neural
development, demonstrated by the failure of to poi some rase

liP knock out mice to

establish neuromuscular junctions (Yang et aI., 2000) and inhibited neuronal
differentiation following its pharmacological inhibition (Tsutsui et aI., 2001) (Nur et aI.,
2007). Topoisomerase II regulates DNA topology by creating a DSB and then passing a
double helix through it (Baldwin and Osheroff, 2005). Topoisomerase II forms a
covalent 5'-phosphotyrosine bond on both strands of DNA (Pommier, 2009). The DSBs
created by topoisomerase Il are always protein-bound and thus do not elicit DNA damage
responses (Nitiss, 2009a).
The poisoning of topoi somerases bound to DNA has been used in anti-cancer
treatments for decades. Camptothecin and etoposide are both derived from plants,

Camptotheca acuminate (Pommier, 2009) and Podophyllum peltatum (Baldwin and
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Osheroff, 2005), respectively. The camptothecin derivative topotecan is currently
approved for treatments of ovarian cancers and small-cell lung cancers, whereas another
derivative, irinotecan, is approved for treatment of colorectal tumors, (Pommier, 2009).
Being of planar aromatic structure, camptothecin stacks between the base pairs next to
the 3' -pho sphotyro sine DNA-protein interface, thereby trapping the topoisomerase I
cleavage complex. Once trapped on the DNA of a post-mitotic cell, a transcription
blockage can result. Indeed, camptothecin is a potent inhibitor of nucleolar transcription
in cancer cell lines (Pommier et aI., 2006). The reversible, trapped topoisomerase
cleavage complex is removed by tyrosyl-DNA-phosphodiesterase I (TDPI) and BER
(Pommier, 2006).
Etoposide is also planar and aromatic, yet its precise mechanism of action remains
unclear. However, it is known that etoposide acts after topoisomerase II has cleaved
DNA, but prior to its relegation (Nitiss, 2009b). Studies have demonstrated that two
molecules of etoposide are required to induce double strand breaks in DNA (Bromberg et
aI., 2003). These findings suggest that, like camptothecin, etoposide inserts itself
between the base pairs next to the 5' -phospho tyro sine DNA-protein interface and
stabilizes the enzyme on the cleaved DNA. Yet the inhibition of topoisomerase II
activity by etoposide has also been demonstrated to produce single strand breaks
(Rogojina and Nitiss, 2008). There are numerous etoposide analogs, one significant to
the work described herein is meso-2,3-bis(2,6-dioxopiperazin-4-yl)butane (ICRF-193), a
topoisomerase II catalytic inhibitor whose activity blocks enzyme turnover by
maintaining it in a closed confirmation. ICRF-193 will therefore have less genotoxic
potential than etoposide.
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Etoposide is one of the most widely used chemotherapy agents, approved by the
FDA in 1983 prior to any knowledge that its target was topoisomerase II (Baldwin and
Osheroff, 2005). Often in combination with cisplatin, etoposide has been used in the
treatment of small-cell lung cancer (Sher et al., 2008), testicular cancer (Feldman et al.,
2008), among others, as well as in intra-arterial delivery to the brain for high grade
astrocytomas (Madajewicz et al., 2000; Newton, 2005). It is also used for pediatric
medullablastoma, primitive neuro-ectodermal tumors, and germ cell tumors. Its use has
been extended as a single agent treatment for pediatric oncology involving
neuroblastoma, leukemia, Ewing's sarcoma, soft tissue sarcoma, osteogenic sarcoma and
Wilms' tumor (Lowis and Newell, 1996). Etoposide has gained clinical attention in the
treatment of pediatric high-grade gliomas because of its effectiveness and reduced risk of
endocrinological and neurocognitive deficits (Dufour et al., 2006).

Ataxia-telangiectasia mutated (ATM) protein kinase
A member of the phosphatidylinositol 3-kinase (PI3K)-like family of serine/threonine
protein kinases (PIKKs), ATM is a 300kD Ser/Thr protein kinase that responds to
genotoxic insult. Named for its causal role in the autosomal recessive disorder, Ataxiatelengiectasia (A-T), A-T mutated protein kinase (ATM) was originally identified
following reduced inhibition of DNA synthesis in response to increasing doses of
ionizing radiation (Houldsworth and Lavin, 1980; Painter and Young, 1980; Lavin,
2008). ATM mediates the signaling of DNA double stranded breaks (DSB) to numerous
downstream targets, including BRCA1, p53, Chk2, CDK2, and H2AX in order to
facilitate a range of cellular processes that include DNA repair and cell cycle control.
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The activated downstream signaling of ATM has been observed to be required for the
cellular response to genotoxic insult (irradiation and etoposide treatment) in the nucleolus
(Kruhlak et aI., 2007), as ATM absence resulted in continued Poll-mediated
transcriptional activity.
To successfully transduce the message of genotoxic damage, ATM must itself be
activated. This activation first involves the monomerization of A TM from its inactive
dimer form, and subsequent activation by autophosphorylation and acetylation (Bakkenist
and Kastan, 2003; Sun et aI., 2007; Sun et aI., 2009; Kozlov et aI., 2011).
Autophosphory1ations at S 1981, S 1893 and S367 are well-characterized and mutations of
these sites in A-T cells are unable to sufficiently correct radiation-induced cell-cycle
defects (Bakkenist and Kastan, 2003; Koz10v et aI., 2006). Interestingly, bacterial
artificial chromosome (BAC) constructs using serines mutated to alanines on these
autophosphorylation sites were introduced into an Atm-I - background and ATM
autophosphorylation and downstream signaling was normal (Pellegrini et aI., 2006;
Daniel et aI., 2008). These findings prompted the identification of additional DNA
damage-induced ATM autophosphorylation sites (Kozlov et aI., 2011).
Recently the identification of ATM activity in its "inactive" dimerized state
provided evidence of a novel DNA repair function. Hydrogen peroxide caused the
activation of the dimerized form of ATM to phosphorylate a substrate, the N-terminus of
a glutathione S-transferase (GST)-p53 in HEK293T cells in vitro (Guo et aI., 201Oa; Guo
et aI., 2010b) in the absence ofDSBs. The authors later confirmed that the
FRAP/ATMlTRRAP C-terminal domain (FATC) was responsible for the oxidative

damage signaling of ATM. A mutation of cysteine residue 2991 allows DSB-induced
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ATM signaling, but is unresponsive to H202. Although autophosphorylation at S198l
was not increased, no other DNA damage-mediated autophosphorylation sites were
evaluated (Guo et aI., 20 lOa; Guo et aI., 20l0b). The importance of these findings is
three-fold: first, a subset of A-T patients, termed A-T variants, exhibit only moderate
radiosensitivity and no immunodeficiency, yet still acquire the primary neurological
component of A-T, ataxia. This mutation results from the entire lack of the last 10 amino
acids on the C-terminus. The protein made from this mutation, R3047X, is fully
activated by the MRN complex, but is not activated by oxidation in vitro (Guo et aI.,
201 Ob). Second, a novel A TM activation pathway has been established with an
activating stimulus that was anticipated, based upon decreased lymphoma incidence and
Olo

the reduced loss of hematopoietic stem cells in Atm mice treated with antioxidants (Ito
et aI., 2004; Reliene and Schiestl, 2007; Reliene et aI., 2008). Lastly, the dimeric form of
ATM accomplishes the signaling mediated by the oxidative stress stimulus (Guo et aI.,
2010a; Guo et aI., 201Ob).

ATM: more than a DNA damage signaling molecule
During the last decade publications have arisen sporadically, which implicate ATM in
non-DNA damage response-related activities. These studies have been prompted by the
varied phenotypic consequences of an insufficiency in ATM, as described by the
autosomal recessive disorder, A-T. A-T patients suffer from high incidences of type 2
diabetes mellitus, progeria, telangiectasias, and neurological phenotypes that include
cerebellar ataxia and speech defects, as well as the expected increased cancer incidence
and radiosensitivity (McKinnon, 2004; Lavin, 2008). Thus, it has been shown that ATM
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is activated by insulin to stimulate translation via the direct phosphorylation of 4 E-BP I ,
which then triggers the phosphorylation-dependent release of 4E-BPI from eIF-4E (Yang
and Kastan, 2000). These studies have been followed up to show that ATM mediates the
activity of AKT to promote survival, without which apoptosis occurs in cycling cells
(Halaby et aI., 2008; Li and Yang, 2010).
The origin of the neurological phenotype associated with A-Tis yet unknown.
Recent work has identified mild to severe cognitive impairments in A-T patients,
consistent with A-T Like Disorders (ATLD). ATLD is rooted in the impaired function of
MRE 11, Rad50, or NBS 1 genes, who respectively code for the proteins that make up the
MRN complex. However, unlike ATLD, the A-T neurological component does not
include microcephaly, but rather cerebellar atrophy and language impairment was
restricted to oral motor impairments (Vinck et aI., 2011). As the most noticeable deficit
is ataxia that usually begins in the second decade of life, it is logical that the identified
speech deficits would be motor-based. The most common theories of the
neurophenotype origin include the inability of neurons to signal damage (oxidative or
DSB) to be repaired.
Neuronal ATM is found in the nucleolus, the nucleoplasm and in the cytoplasm
(Gorodetsky et aI., 2007). Recent work has indicated that the cytoplasmic form of ATM
signals to synapsin-l, a vesicle component, to regulate neurotransmitter release (Li et aI.,
2009), the absence of which has profound effects on hippocampal long-term potentiation
in mice. The implications of this work include the novel function of A TM, its residencespecific function, and the likely contribution to the neurological component of A-T.
While the nucleolar enrichment of ATM prompted speculations about its possible role in
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maintaining the high rate of nucleolar transcription, perhaps by repairing transcription
related DNA damage (Gorodetsky et aI., 2007), experiments testing such a notion have
not yet been reported.

Targets promoting sufficient neuronal nucleolar transcription
Collectively, nucleolar transcription appears critical for neurons in regulating their
growth. In addition, by ribosomal renewal and stress sensing including monitoring of
genomic integrity, the nucleolus plays an essential role in neuronal maintenance. Finally,
the nucleolus appears to be a target of neurodegeneration. However, regulation of
nucleolar transcription in neurons remains poorly understood. In particular, when this
work began it had not been known whether DNA damage could disrupt neuronal
nucleolar transcription in the intact animal brain and whether such a disruption may occur
in mature adult neurons. Additionally, no signaling pathway other than ERKl/2 had been
implicated as a regulator of neuronal Poll. This study took advantage of the
topoisomerase-II poison, etoposide, to test the hypothesis that nucleolar transcription is
sensitive to DNA damage in whole animal brains and that such sensitivity is not agerestricted. In addition, we followed accidental observations suggesting ATM's
involvement in Poll regulation and tested the hypothesis that this kinase stimulates
neuronal Poll transcription while regulating neuronal growth upon neurotrophic
stimulation.
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CHAPTER II
NUCLEOLAR DISRUPTION AND APOPTOSIS ARE DISTINCT NEURONAL
RESPONSES TO ETOPOSIDE-INDUCED DNA DAMAGEa

'Published: Pietrzak M*, Smith SC*, Geralds JT, Hagg T, Gomes C, Hetman M.

J ofNeurochem 117(6):1033-46. 2011. *equal contribution

Introduction
Oxidative damage to neuronal DNA, including chemical modifications of DNA
bases and single strand breaks (SSBs), is well-documented in several age-dependent
neurodegenerative conditions including Alzheimer's- or Parkinson's diseases
(Markesbery and Lovell, 2006; Martin, 2008a). In addition, the accumulation of
oxidative DNA damage in neurons has been demonstrated during brain aging (Brasnjevic
et aI., 2008; Yankner et aI., 2008). However, it is unclear whether such genomic injuries
contribute to age-related neurodegeneration or represent an epiphenomenon of oxidative
stress. Therefore, it is critical to test whether the neurodegeneration-associated forms of
DNA damage result in neurotoxic consequences in the adult or aging brain.
Studies of neurons from embryonic and/or neonatal rodents have identified
apoptotic cell death as a major neuronal response to DNA damage. Neuronal apoptosis
has been observed following challenges with DNA strand break inducers, such as
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topoisomerase inhibitors or ionizing irradiation (Enokido et aI., 1996; Morris and Geller,
1996; Herzog et aI., 1998; Martin et aI., 2009). However, that effect is limited to
relatively immature neurons (Herzog et aI., 1998; Martin et aI., 2009). Therefore, a nonapoptotic response to neuronal DNA damage may be more relevant for the pathogenesis
of age-dependent neurodegenerative diseases.
Genetic defects of several DNA repair pathways, including those for single- or
double DNA strand breaks (SSBs or DSBs, respectively) as well as large chemical
modifications of DNA bases that are also known as 'bulky' DNA ad ducts (Brooks, 2008;
Caldecott, 2008; Katyal and McKinnon, 2008) provide a strong argument for a causative
role of DNA damage in common neurodegenerative disorders. For instance, deficiencies
of the DSB repair kinase ataxia telangiectasia-mutated protein kinase (ATM) trigger
delayed neurodegeneration, presumably by blocking the developmental apoptosis of
newly generated neurons harboring chromosomal abnormalities (Katyal and McKinnon,
2008). In contrast, the SSBlbulky adducts repair deficits may induce neurodegeneration
by the progressive and age-dependent accumulation ofunrepaired DNA damage that
reduces neuronal transcription (Brooks, 2008; Caldecott, 2008; Katyal and McKinnon,
2008). In the nervous system of whole animals, evidence for linking such genomic
lesions to transcriptional insufficiency has not yet been reported.
The nucleolus is a site of ribosomal biogenesis (Grummt, 2003; Drygin et aI.,
2010). That process is initiated by the RNA-Polymerase-l (Poll)-driven transcription of
nucleolar rRNA genes. Continuous Poll activity is required for maintaining nucleolar
structure. Consequently, Poll inhibition results in nucleolar disruption, which triggers
the release of various proteins whose localization is normally restricted to nucleoli. Upon
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release from the nucleolus some of those proteins lead to the activation of the proapoptotic p53 pathway (Rubbi and Milner, 2003; Yuan et aI., 2005). In proliferating
cells, this mechanism has been proposed to underlie the cytotoxic effects of several DNA
damaging anti-cancer drugs (Rubbi and Milner, 2003; Burger et aI., 2010). Work from
our laboratory has demonstrated that in cultured cortical neurons from newborn rats, the
DNA damaging DNA-Topoisomerase-l (Topol) inhibitor camptothecin results in Poll
inhibition and nucleolar stress, which is sufficient to induce p53-dependent apoptosis
(Kalita et aI., 2008). Hence, nucleolar transcription may serve as a sensor of neuronal
DNA damage including such camptothecin-induced DNA lesions as SSBs or Topol
cross-links to DNA. The consequences of activating such a sensing mechanism could be
p53-mediated apoptosis or a chronic reduction of ribosomal biogenesis if the apoptotic
response is disabled.
Etoposide is a widely-used anti-cancer drug that, by inhibiting DNAtopoisomerase-2 (Top02), induces DSBs, SSBs and Top02-DNA cross-links (Nitiss,
2009b). In humans, etoposide-containing multidrug chemotherapy has been associated
with mild cognitive impairment in children and adults (Kaasa et aI., 1988; Mok et aI.,
2005; Whitney et aI., 2008; Riva et aI., 2009). In adult rats, acute neurotoxicity has been
reported following intracarotid etoposide injections that were combined with the osmotic
disruption of the blood-brain barrier (BBB) using mannitol (Maeda et aI., 1999; Fortin et
aI., 2007). To date, there have been no published studies investigating mechanisms of
etoposide-induced neurotoxicity in whole animals. The current study was performed to
determine whether nucleolar stress occurs following etoposide-mediated neuronal DNA
damage and whether such a response is developmentally-restricted.
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Materials and Methods

Animals
Sprague-Dawley rats were purchased from Harlan (Indianapolis, IN, USA). All
animal experiments strictly followed the protocols that were approved by the Institutional
Animal Care and Use Committee of the University of Louisville and the NIH guidelines.

Materials
The following antibodies and reagents were obtained from commercial sources:
anti-p53 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti- (phospho-Ser15)-p53
(Cell Signaling Technology, Danvers, MA, USA); anti-B23 (mouse monoclonal; Santa
Cruz Biotechnology); anti-(Asp175)-cleaved caspase 3 (rabbit polyclonal; Cell Signaling
Technology); anti-bromo-deoxyuridine (anti-BrdU, mouse monoclonal; Sigma, St Louis,
MO, USA); anti-p-galactosidase (rabbit polyclonal anti-p-gal; MP Biomedicals, Solon,
OH, USA); anti-HA (mouse monoclonal; Roche Diagnostics, Indianapolis, IN, USA),
anti-p-actin (mouse monoclonal; Sigma); anti-microtubule-associated protein 2 (MAP2)
(mouse monoclonal; Cell Signaling Technology), and anti-phospho-Ser1981-ATM
(mouse monoclonal; Cell Signaling Technology); horseradish peroxidase-conjugated
anti-mouse or anti-rabbit IgG antibodies (Calbiochem, San Diego, CA, USA); Alexa 488, Alexa 594-conjugated secondary antibodies, and, Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA); camptothecin, etoposide, ICRF-193, 5-fluorouridine (5FU); 4hydroxytamoxifen (4HT) (Sigma). Respective IgG antibodies were used in place of
primary antibodies as a negative control (data not shown).
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Intracarotid artery injections of etoposide
Young adult male rats (8-10 weeks old, 200-250 g) were deeply anesthetized
with an intramuscular injection of3.3 mLlkg mixture containing 25 mg/mL ketamine
hydrochloride (Abbott Laboratories, Abbott Park, IL, USA), 1.2 mg/mL acepromazine
maleate (The Butler Company, Dublin, OH, USA), and 0.25 mg/mL xylazine (The Butler
Company) in 0.9% saline. A midline incision on the neck, longitudinally, to the jugular
notch was then made. Blunt dissection through the fat pad to separate the sterno-hyoid
from sterno-mastoid muscles proceeded. An aIm retractor was applied to separate the
omo-hyoid and sterno-mastoid muscles. The omo-hyoid was lifted, cut and reflected
laterally. The common carotid was carefully dissected from the vagus and sympathetic
nerves using a #7 Dumont forceps. A 6.0 size suture was placed under the most caudal
aspect of the common carotid artery and lifted to temporarily occlude it. A 30 gauge
needle attached to a syringe via a catheter was inserted into the carotid just rostral to the
occlusion for injection of 20%D-mannitol and 15 mg/kg etoposide. Three milliliters of
mannitol was infused over 30 s followed by a 5-min pause prior to the slow infusion of
1 mL etoposide or 20% dimethylsulfoxide (DMSO) in 0.9% saline. After completion of
the injection, a microaneurysm clip was applied to the most rostral aspect of the exposed
common carotid artery. Quick stop powder was applied to quickly promote coagulation
and the suture was removed. The microaneurysm clip was removed prior to closing the
incision with wound clips.
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Intracerebroventricular injection

Rat pups received injections at postnatal day 7 (P7) based on a previously
described method (Han and Holtzman, 2000). The injections of 5 JlL artificial CSF
(126 mM NaCI, 25 mM NaHC0 3 , 25 mM glucose, 1.25 mM NaH2 P04 , 2.5 mM KCI,
I mM MgCI) I 20%DMSO ± 10 nmoles etoposide were made with a Hamilton needle
inserted into the left lateral ventricle at the following coordinates: 1.5 mm rostral- and
1.5 mm lateral to lambda (incorrectly named Bregma in (Han and Holtzman, 2000), Dr
David Holtzman, personal communication), 2 mm deep from the skull surface. Lambda
was readily identified by the underlying venous sinuses which were visualized by shining
light from two focal sources placed on either side of the head (D. Holtzman, personal
communication). After injection, animals were placed back with their mother.

Cell culture and transfection

Cortical neurons were isolated from newborn Sprague-Dawley rats at postnatal
day 0 as described previously (Habas et aI., 2006). Neurons were cultured in basal
medium Eagle supplemented with 10% heat-inactivated bovine calf serum (Hyclone,
Logan, UT, USA), 35 mM glucose, 1 mM L-glutamine, 100 U/mL of penicillin and
0.1 mglmL streptomycin or Neurobasal AlB27 medium (Invitrogen). On day in vitro 2
(DIV2), 2.5 JlM cytosine arabinoside was added to cultures to inhibit the proliferation of
non-neuronal cells. Cells were used for experiments on DIV5-6 unless indicated
otherwise.
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Drug treatment of cultured neurons
For treating cultured cells, etoposide, camptothecin, ICRF-193 or 4HT were
dissolved in DMSO or methanol, respectively. The final media concentration of the
solvents was 0.2%.

RNA isolation and quantitative RT-PCR
Following CO2 euthanasia, the entire rat neocortex was harvested and
immediately frozen on dry ice. Tissue RNA extraction was done following
homogenization with a pestle grinder (Fisherbrand; Fisher Scientific, Pittsburgh, PA,
USA) in 1 mL TRI Reagent (Sigma) at 4°C. Cultured cell RNA was isolated from
5

x

10 6 cells/sample using TRI Reagent. The random hexamers-primed eDNA synthesis,

quantitative RT-PCR, and the

~~ct-based

analysis of 45S pre-rRNAl18S rRNA levels

were done as described previously (Kalita et aI., 2008).

Immunofluorescence
Deeply anaesthetized rats were transcardially perfused with ice cold PBS, and
then with 4% paraformaldehyde in PBS. Following 24 h post-fixation, brains were
cryoprotected for up to 72 h in 30% sucrose and sectioned on a cryostat at 25
(P7 rats) or 30

~m

~m

sections

sections (adult rats), and mounted on slides. For B23 staining, epitope

rescue was carried out in 10 mM sodium citrate buffer, 0.05%Tween, pH 6.0 for 20 min
at 90°C. Then, sections were incubated in blocking solution [3% bovine serum albumin,
10% normal goat serum in PBS/0.1 % Triton-Xl 00 (PBST), 1 h] followed by primary and
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secondary antibodies (anti-B23, 1:100,48 h at 4°C and anti-mouse-IgG-Alexa-488,
1: 100, 4 h at 20°C, respectively). Activated caspase 3 (Asp 175) immunostaining was
performed following a standard protocol. Briefly, after 1 h blocking (3% bovine serum
albumin, 5% normal goat serum in PBST), sections were incubated with an antibody
specific for the cleaved, activated caspase 3 (1 : 100, over night at 4°C) followed by an
Alexa-488-labled secondary antibody (1 : 100, 1 h at 20°C). Nuclei were visualized by
Hoescht-33258. Then, sections were covered with coverslips that were mounted using
Fluoromount G (Southern Biotech, Birmingham, AL, USA).

Image acquisition and analysis
Images were captured using the Nikon Eclipse TE2000-S or the Zeiss
AxioObserver inverted microscopes with MetaMorph or Axio Vision software,
respectively. Fluorescent exposure rates were kept consistent across all conditions by
fluorescent filter. Images were exported as TIF files with and without scale bar
annotations. Both the annotated and unannotated TIF images were further scaled in
Photoshop7 (Adobe Systems Incorporated, San Jose, CA, USA) and a line of appropriate
font was applied to the unannotated TIF that matched the size of the annotated TIF in
Adobe Illustrator 10 (Adobe).

Evaluation of apoptosis
Apoptosis was evaluated by nuclear morphology. Cells were stained with
Hoechst 33258 and anti-cleaved caspase-3 observed using fluorescent microscopy. Cells
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with condensed or fragmented nuclei were scored as apoptotic. Though quantifications
were not provided in figures shown in this thesis, in vitro quantification provided in the
published work were conducted by counting both Hoechst 33258-stained apoptotic
bodies and live nuclei. Total apoptotic nuclei were divided by the summed total of
counted nuclei (healthy and apoptotic) to determine the apoptotic ratio. No less than 300
cells were counted and all areas of the stained coverslip were included in the calculations.

Statistical analysis

Statistical analysis of the data was performed using one-way ANOV A. Error bars were
expressed as standard errors of the mean.

Results

Nucleolar stress in cortical neurons of etoposide-treated rats

To investigate the nucleolar consequences of etoposide-induced DNA damage in
adult rats, we performed intracarotid injections of 15 mg/kg etoposide immediately after
osmotic BBB disruption with 20% mannitol. Although such delivery may reach various
parts of the brain, we focused our analysis on the neocortex. Four hours after etoposideinjection, the neocortical45S pre-rRNAll8S rRNA ratio decreased to 0.51-fold of
vehicle-treated controls (Fig. 4A, p < 0.05). As 45S pre-rRNA is the primary Poll
transcript that is rapidly processed to mature rRNA species, including 18S rRNA, the
declining 45SI18S ratio indicates Poll inhibition (Kalita et aI., 2008). This conclusion is
further supported by the immunostaining for the nucleolar marker B23/nucleophosmin
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(Fig. 4B), as nucleolar localization of that protein depends on active Poll (Rubbi and
Milner, 2003; Kalita et aI., 2008). Hence, upon Poll inhibition, B23 is released from the
nucleoli and diffuses throughout the nucleoplasm (Rubbi and Milner, 2003; Kalita et aI.,
2008). In vehicle-, but not etoposide-injected rats, B23 immunostaining was
concentrated in the nucleoli of neocortical cells (Fig. 4B). Six hours after etoposide
treatment, B23 immunostaining became uniformly distributed in the nucleoplasm of
those cells, suggesting that they are under nucleolar stress (Fig. 4B). The nucleolar stress
was present in virtually all neocortical cells (Fig. 4B, and data not shown). Hence, in
cortical neurons of adult rats, nucleolar disruption is a response to the DNA damaging
drug etoposide.

To determine whether such a response is also present in the developing brain, 7-day
old rats were administered 10 nmoles of etoposide by a single injection into the right
lateral ventricle. After 4 h, the declining ratio of 45S pre-rRNAl18S rRNA indicated
Poll inhibition in the ipsilateral neocortex of etoposide-treated animals (Fig. 5A). In
addition, etoposide induced a partial release of nucleolar B23 in almost all analyzed cells
from the ispilateral neocortex (Fig. 5B). Therefore, the etoposide-induced nucleolar
stress response occurs both in developing and mature cortical neurons of whole rats.

35

Figure 4

A
"i" 1.2
Cl

:;; 1.0
.r;

u 0.8

'tJ

g 0.6
~ 0."

II::

.. 0.2
GO

a.

0 "-_~_ _~~_
o
15

etoposide (mg/kg)

B
etoposide (mg/kg)

o

15

Figure 4: Nucleolar disruption in the neocortex of etoposide-treated adult rats.
Rats were infused with 0 or 15 mg/kg etoposide that was administered into the right
intracarotid artery immediately after BBB disruption with 20% d-mannitol. (A) At 4 h
after etoposide treatment, reduced nucleolar transcription was observed in the ipsilateral
neocortex as indicated by the declining expression ratio of the primary nucleolar rRNA
transcript (45S pre-rRNA) to the mature 18S rRNA. The rRNA levels were determined
by quantitative real-time peR; data are mean ± SE of four animals per group; *p < 0.05.
(B) At 6 h after etoposide treatment, nucleolar stress was observed throughout the
ipsilateral neocortex as indicated by the loss of nucleolar immunofluorescence of
nucleolphosminIB23. B23, which under control conditions was concentrated in nucleoli
(arrows), displayed a diffused staining pattern throughout the nucleoplasm in etoposideinfused rats (arrowheads). Note that cells with nucleolar stress had normal chromatin
structure as visualized by counter-staining with Hoechst-33258. Representative
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photomicrographs of cortical layer IV-VI are shown; similar effects of etoposide on B23
localization were observed in three animals.
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Figure 5: Nucleolar disruption in the neocortex of etoposide-treated newborn rats.
At postnatal day 7 (P7), rats received 0 or 10 nmoles etoposide that was administered by
an injection into the right lateral ventricle. (A) Four hours after etoposide injection,
nucleolar transcription was suppressed in the ipsilateral neocortex. Data are means ± SE
of four animals per group; **p < 0.01. (B) Six hours after etoposide injection, nucleolar
stress was present in the ipsilateral neocortex. Reduced nucleolar B23 staining together
with its diffused appearance throughout the nucleoplasm was observed in most
neocortical cells (arrowheads). B23 under control conditions was concentrated in
nucleoli (arrows) . Note that cells with nucleolar stress had normal chromatin structure as
visualized by counter-staining with Hoechst-33258 . Representative photomicrographs of
cortical layer IV-VI are shown; similar effects of etoposide on B23 localization were
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observed in four animals.

Etoposide-induced apoptosis is developmentally-restricted
Conversely, etoposide triggered apoptosis in developing, but not mature cortical
neurons. In the neocortex of vehicle-injected neonates, immunostaining for the activated
form of caspase 3 revealed rare apoptotic cells (up to 2-3 cells/section) (Fig. 6A-C, and
data not shown). In contrast, numerous cells with active caspase 3 were observed in the
neocortex of etoposide-injected neonates at 6 h post-injection (Fig. 6D, F, H). Such cells
were most frequent in the proximity of the injection site and spread throughout all
cortical layers. In addition to active caspase 3, they often displayed apoptotic chromatin
condensation (Fig. 6E, G). The morphology of some active caspase 3-positive cells
revealed neuronal features, including pyramidal perikaria and neurites (Fig. 6D, F). In
addition, cells with apoptotic rounding of the shrunken cell bodies were also present (Fig.
6H). Although most apoptotic cells were identified in the ipsilateral neocortex, their
increased incidence was also noticed on the contralateral side (data not shown). After
24 h, few apoptotic cells were present and tissue destruction was observed around the
etoposide-, but not the vehicle injection site (data not shown). Neither caspase 3
activation nor apoptotic chromatin condensation was present in the neocortex of
etoposide- or vehicle- treated adult rats (Fig. 6I-N).
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Figure 6: Etoposide-induced apoptosis in the neocortex of the neonate, but not the
adult rats.
Neonate (P7) (A-H) or adult rats (I-N) were treated as described for Figs 5 and 4,
respectively. Six hours after etoposide (Etop) administration apoptosis was identified by
the presence of immunofluorescence for activated caspase 3 and/or
condensation/fragmentation of nuclear chromatin that was visualized by counter-staining
with Hoechst-33258. Photomicrographs of the ipsilateral neocortex are shown. Three
animals were analyzed for each condition. Cortical layers are indicated by roman
numerals. (A-H) Activated caspase 3 and apoptotic chromatin rearrangements in
neocortical cells of etoposide-treated neonates (arrows). Presence of active caspase 3 in
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neurites suggests neuronal identity of many apoptotic cells (arrowheads). (I-N) Absence
of apoptotic cells from the neocortex of etoposide-treated adult rats.
The pronounced apoptotic response was also present in the hippocampi of the
etoposide-treated neonatal rats (Fig. 7D-F). Apoptotic cells were most frequent in the
granule cell layer of the ipsilateral dentate gyrus (Fig. 7D-F). Increased frequency of
such cells was also observed on the contralateral side (data not shown). Finally, some
caspase 3-positive cells appeared in the pyramidal cell layer of the ipsilateral
hippocampus (data not shown). As in the neocortex, no evidence for etoposide-induced
apoptosis was found in the adult hippocampi or other analyzed structures of the adult rat
brain (Fig. 7G-L, and data not shown). Therefore, unlike nucleolar stress, apoptosis is a
developmentally restricted response to etoposide-induced DNA damage.
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Figure 7
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B

Figure 7: Etoposide-induced apoptosis in the hippocampus of the neonate, but not
the adult rats.
Neonate (P7) (A-F) or adult rats (G-L) were treated as described for Figs. 5 and 4,
respectively. Six hours after etoposide (Etop) administration apoptosis was identified as
in Fig. 6. Photomicrographs of the ipsilateral hippocampi are shown. Three animals
were analyzed for each condition. (A-F) Etoposide-induced activation of caspase 3, and
apoptotic chromatin rearrangements in granule cells of the neonate dentate gyrus
(arrows). (G-L) Absence of apoptotic cells from the dentate gyrus of etoposide-treated
adult rats.

41

Etoposide-induced damage of neuronal DNA causes nucleolar disruption
As in whole animal studies, the neuronal effects of a drug may be indirect,
cultured cortical neurons from newborn rats were used to test whether nucleolar
disruption is caused by etoposide-induced damage of neuronal DNA. In neurons that
were incubated for 8 h with etoposide, the 45SI18S rRNA ratio decreased in an etoposide
concentration-dependent manner (Fig. 8). Declines to 0.64- or 0.55-fold of vehicletreated controls were triggered with 25- or 50 11M etoposide, respectively, indicating Poll
inhibition. In contrast, 10 11M etoposide did not affect the 45S/18S rRNA ratio.
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Figure 8: Etoposide-induced nucleolar stress in cultured cortical neurons from
newborn rats.
At DIV5, rat cortical neurons were treated with etoposide for 8 h as indicated. At
etoposide concentrations of25- or 50- but not 10 JiM, the ratios of 45S pre-rRNAl18S
rRNA levels declined, suggesting inhibition of Poll-mediated transcription. Data
represents mean ± SE of three independent experiments; *p < 0.05; **p < 0.01.
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Discussion
In this study, we obtained evidence that the DNA damaging drug etoposide
inhibits Poll-mediated transcription triggering nucleolar stress in both developing and
mature cortical neurons of whole rats. That contrasts with neuronal apoptosis, whose
induction by etoposide appears developmentally-restricted. Hence, we propose that
nucleolar disruption is a DNA damage response that occurs in both young and adult
neurons and, as such, may contribute to neurotoxic consequences DNA strand breaks that
are associated with neurodegenerative diseases.
Etoposide was used to investigate the nucleolar effects of neuronal DNA damage
in whole animals. For adult rat studies, we applied that agent by intracarotid injection
that was performed immediately after osmotic disruption of the BBB. That method was
chosen because of its demonstrated effectiveness in delivering etoposide to the adult
animal- or human brain (Maeda et aI., 1999; Fortin et aI., 2007). Using that technique,
we showed nucleolar disruption, but no apoptosis in the ipsilateral cortices of rats
receiving 15 mg/kg etoposide. By 5 h after injecting such a dose, all animals displayed
signs of systemic drug toxicity including hypoactivity and slowed breathing. Therefore,
it is possible that the disruption of nucleolar B23 at 6 h after treatment may be a
secondary response to such toxicity. However, Poll inhibition was also observed in all
animals at 4 h post-injection when the first signs of systemic toxicity were present in five
of eight treated rats. In addition, nucleolar stress was induced in cortical neurons of
young animals that received etoposide by intracerebroventricular injection and remained
in excellent health for at least 24 h post-treatment. Finally, in cultured cortical neurons
that were directly exposed to etoposide, nucleolar disruption was present. Therefore, the
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etoposide effects on the nucleolar integrity of cortical neurons are likely associated with
its direct genotoxic actions in those cells. Indeed, in the developing rat neocortex, we
observed etoposide-induced nucleolar stress and apoptosis without any signs of major
systemic toxicity. Hence, intracerebroventricular injection of etoposide provides a
convenient model to investigate consequences of neuronal DNA damage in whole rat
pups.
As excessive accumulation of DNA strand breaks is associated with neuronal
dysfunctionlneurodegeneration. Nucleolar stress may be among the neurotoxic effector
mechanisms that are triggered by such genotoxic lesions. While in common
neurodegenerative diseases the genotoxic frequency will unlikely reach the levels that
will be needed for a complete block of Poll-driven transcription and the consequent
disruption of the nucleolar structure, they may reduce ribosomal biogenesis to such levels
that will be insufficient to maintain fully functional protein synthesis machinery, thereby
leading to neuronal atrophy including loss of synapses. Of note, reduced ribosomal
biogenesis is suggested in the Alzheimer's Disease-associated cerebro-cortical pathology
that also involves oxidative DNA damage (Ding et aI., 2005; Honda et aI., 2005;
Markesbery and Lovell, 2006). Therefore, DNA damage-induced nucleolar stress may
contribute to Alzheimer's Disease.
In conclusion, our results demonstrate that Poll inhibition is a neuronal response
to DNA damage that is not developmentally restricted, while neuronal apoptosis is a
developmentally-restricted DNA damage response. Hence, nucleolar stress may be one
of the neurotoxic effector mechanisms of DNA damage in the adult/aging brain.
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CHAPTER III
REGULATION OF RNA POLYMERASE-I-MEDIATED TRANSCRIPTION BY
ATAXIA TELEANGIECTASIA MUTATED (ATM)

Introduction
Ataxia-telangiectasia mutated (ATM) is a protein kinase that belongs to the PI3K
family including such members as mTOR, PI3K, DNA-PK, ATR and SMG-l. ATM is
activated by DNA double-stranded break (DSB) damage, thereby playing an important
role in the DNA damage response (Herzog et aI., 1998; Gatti et aI., 2001; Biton et aI.,
2008; Lavin, 2008). Its absence or insufficiency causes the autosomal recessive disorder
Ataxia-telangiectasia (A-T), which is characterized by cancer predisposition,
immunodeficiency, and neurodegeneration leading to cerebellar ataxia (Lavin and Shiloh,
1997; Gatti et aI., 2001; McKinnon, 2004). The A-T associated neurodegeneration
includes Purkinje and granule cell loss in the cerebellum and may also be present in other
brain structures such as forebrain, brain stem and spinal cord (Lavin and Shiloh, 1997;
Biton et aI., 2008; Li et aI., 2011). The mechanisms ofneurodegeneration in A-T patients
remain unknown.
There are several functions of ATM that appear unrelated to its involvement in
the DNA damage response. In addition to mTOR, ATM directly phosphorylates 4E-BPI
increasing translation in insulin-stimulated cells (Yang and Kastan, 2000). Similarly
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ATM has been shown to activate AKT to promote cellular survival (Li and Yang, 2010).
The CREB-dependent differentiation of human SH-SY5Y neuroblastoma cells also
requires ATM (Fernandes et aI., 2007). At the synapse, ATM regulates neurotransmitter
release, contributing to synaptic plasticity (Li et aI., 2009). Such multi-functionality of
A TM is supported by its widespread distribution throughout the cell including the
nucleus, nucleolus, vesicles and cytoplasm (Gorodetsky et aI., 2007; Lavin, 2008; Li et
aI.,2009). Indeed, the functional versatility of ATM may explain the complex pathology
of A-T.
The nucleolus is a transcription-dependent structure that contains clustered
repeats of the 45S rRNA genes (ribosomal DNA, rDNA). The transcription ofrDNA by
RNA Polymerase-I (Poll) is the first step of ribosomal biogenesis (Grummt, 2003;
Drygin et aI., 2010). By controlling ribosomal biogenesis, Poll activity determines cell
proliferation and cell growth. Therefore, Poll is tightly regulated to adjust ribosomal
biogenesis to cellular needs and resources (Grummt, 2003). Indeed, cellular growth,
including neurite outgrowth, requires growth factor-dependent activation of Poll that is
mediated by ERK1I2- and mTOR signaling pathways (Grummt, 2003; Mayer et aI.,
2004; Drygin et aI., 2010; Gomes et aI., 2011). Conversely, Poll is inhibited by cellular
injury including DNA damage (Mayer and Grummt, 2005; Kruhlak et aI., 2007; Kalita et
aI., 2008; Pietrzak et aI., 20llb). Finally, insufficiency of nucleolar transcription to
replenish neuronal ribosomes has been proposed as a mechanism of neurodegeneration
(Hetman & Pietrzak, accepted, TINS).
While searching for DNA damaging agents that inhibit neuronal Poll, we
observed its unexpected stimulation in response to DNA topoisomerase-II inhibitors that
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was A TM dependent. Therefore, we conducted further experiments to detennine whether
(i) regulation of Poll by stimuli promoting neuronal growth required ATM, (ii) ATM was
necessary for neuronal growth and (iii) ATM regulated Poll in immortalized proliferating
cells.

Materials and Methods

Animals
All animal experiments strictly followed the protocols that were approved by the
Institutional Animal Care and Use Committee of the University of Louisville and the
NIH guidelines. Newborn Sprague-Dawley rats at PO were used for cell culture.
Postnatal day 7 rats were used for in vivo studies. Cerebellar and cortical A TM-1- mouse
tissues were from a previously described line of ATM knock out mice (Herzog et aI.,
1998).

Materials
The following reagents were obtained from the indicated commercial sources:
mouse monoclonal anti-B23 antibody and mouse monoclonal anti-ATM antibody, Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA); 5-ethynyl uridine (5-EU, Berry and
Associates, Dexter, MI); Actin-RFP, Alexa 488-, Alexa 594-conjugated secondary
antibodies, Oregon Green®-6-carboxamido-(6-azidohexanyl) triethylammonium salt,
(Oregon Green®-azide), and Lipofectamine 2000, Invitrogen (Carlsbad, CA, USA);
BDNF (Alomone Labs, Jerusalem, Israel); anti-ERK1I2 antibodies, anti-phospho-
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(S1981)-ATM mouse monoclonal antibody, anti-phospho-(S473)-AKT rabbit polyclonal
antibody, anti-phospho-(T389)-RPS6 mouse monoclonal, anti-RPS6 rabbit monoclonal,
anti-MAP2 rabbit polyclonal, Cell Signaling (Beverly, MA, USA), antiphospho-ERK1I2
antibody (anti-ACTIVE_ MAPK pAb), Promega (Madison, WI, USA); horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies and LY294002,
Calbiochem (San Diego, CA, USA). KU55933, SR-95531, and KU0063794, Tocris
(Ballwin, MO, USA). All other reagents were purchased from Sigma (St. Louis, MO).
Respective IgG antibodies were used in place of primary antibodies as a negative control
and resulted in background staining (data not shown).

Cell culture
Cortical or hippocampal neurons were prepared from newborn Sprague-Dawley
rats at PO as previously described (Habas et aI., 2006). Briefly, the culture medium was
Basal Medium Eagle (BME) supplemented with 10% heat-inactivated bovine calf serum
(Hyclone, Logan, UT), 35 mM glucose, 1 mM L-glutamine, 100 U/mL of penicillin and
0.1 mg/mL streptomycin. Cytosine arabinoside (2.5 11M) was added to cultures on the
second day after seeding (day in vitro 2, DIV2) to inhibit the proliferation of nonneuronal cells. Cells were used for experiments at DIV 5-6, with the exception of
neuronal activity-dependent experiments and morphogenesis experiments. Neuronal
activity experiments were conducted on DIV 8 to allow for neurons to develop a network
of processes with synaptic contacts and express functional NMDA-type and AMPA
glutamate receptors (Papadia et aI., 2005). For morphogenesis experiments neurons
were transfected on DIV 3, treated on DIV 4 and fixed 24 h later (DIV5).
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Serum starvation of cultured cortical neurons. Serum starvation of cultured
cortical neurons has been described previously (Kharebava et aI., 2008). Briefly, on DIV
5-6, cells were washed twice with serum free BME and placed in BME medium
containing MK-80 I and AraC. Two hours later, BDNF (lOng/mL) and/or inhibitors were
added to the medium for an additional 2 h.
Serum stimulation of cell lines. Immortalized cells were cultured in DMEM
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin and
plated at a density of approximately 2 X 106 /35 mm dish. Serum starvation was
conducted by washing cells twice with serum free DMEM followed by placement in
serum free DMEM supplemented with antibiotics for 12-14 h. Then, cells were placed
back in the full growth medium in the presence or absence ofKU55933.

Intracerebroventricular injection
ICV injection into the P7 rat has been described previously (Pietrzak et aI.,
2011 b). Briefly, injections of 5 /-lL artificial cerebrospinal fluid (aCSF: 126 mM NaCI, 25
mM NaHC03, 25 mM Glucose, 1.25 mM NaH2 P04 , 2.5 mM KCI, 1 mM MgCh) /20%
DMSO ± pharmacological agent (etoposide, ICRF-193, KU55933) were made with a
Hamilton needle inserted into the right lateral ventricle at the following coordinates: 1.5
mm rostral- and 1.5 mm lateral to lambda, 2 mm deep from the skull surface. Lambda
was readily identified by the underlying venous sinuses which were visualized by shining
light from two focal sources placed on either side of the head, or one light source beneath
the chin. After injection, animals were placed back with their mother.
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Transfection ofDNA
An expression plasmid for alpha-acti Red Fluorescent Protein (alpha-actin RFP)
was transiently transfected into cortical neurons on DIV 3. First, the conditioned medium
was removed and saved; Cells were then placed in serum-free basal Eagle's medium
(Sigma) supplemented with 1.5 IlLlmL 20mM glucose containing 0.5 Ilg of DNA mixed
with 1.5 ilL of Lipofectamine/weli. After a 40 min incubation at 5% CO 2 and 37 °C, the
transfection medium was replaced with conditioned medium. Cells were fixed for 15-30
minutes at room temperature and immunostained 2 days after transfection.

Image acquisition/Morphogenesis
Images were captured using the Zeiss AxioObserver inverted microscopes with
MetaMorph or AxioVision software, respectively. Fluorescent exposure rates were kept
consistent across all conditions by fluorescent filter. Images were exported as TIF files
with and without scale bar annotations. Both the annotated and unannotated TIF images
were further scaled in Photoshop7 (Adobe Systems Incorporated, San Jose, CA, USA)
and a line of appropriate font was applied to the unannotated TIF that matched the size of
the annotated TIF in Adobe Illustrator 10 (Adobe).
Morphogenesis images were captured on Zeiss Axio Observer inverted
microscope and AxioVision software at 20X magnification. NeuronStudio (Weame et
aI., 2005; Rodriguez et aI., 2008) was used to hand-trace neurites from the soma. An
average of 13 representative cell images were analyzed per condition per culture. The
researcher collecting images and conducting the tracing was blinded to each of the
experimental conditions while conducting this work. Images were accessed by the
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presence of healthy nuclei, evaluated by Hoechst 33258 nuclear staining, alpha-actinRFPpositive fluorescence, and the absence of neurite beading (an indicator of progressing
degeneration) .

Drug treatment
Etoposide, ICRF-193, LY294002, U0126, KU55933, KU0063794, MK-801,
SR95531 (Gabazine), and 4-AP were dissolved in dimethyl sulfoxide (DMSO).
Inhibitors were added to the medium 20 minutes prior to stimulation by etoposide, ICRF193, BDNF or Gaba/4-AP. The final media concentration of the solvents was 0.2%.

In situ run-on assay
The RNA precursor, 5-EU, was used as described previously (Gomes et aI.,
2011). Briefly, to label nascent RNA, glass coverslip-cultured cells were incubated with
1 mM 5-EU for one hour (37°C, 5% CO2 ) followed by fixation with 4%
paraformaldehyde. Co-immunofluorescence for the nucleolar marker B23 was performed
according to standard protocols. Following incubations with the secondary antibodies,
the 5-EU-labeled nascent RNA was detected using the previously described "click"
chemistry methodology (Jao and Salic, 2008). The "click" buffer (1 M tris-HC1, pH 8.5;
100 mM CUS04, 0.5 M ascorbic acid, 5 mM Oregon Green® azide in DEPC-treated
water) was applied for 30 min followed by a wash with PBS and mounting of the
coverslips on to slides. The integrated brightness density of 5-EU was calculated in the
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B23-positive nucleoli using the NIH freeware Image-J. For each cell, nucleolar signal
was normalized against the 5-EU staining in the whole nucleus.

Western blot analysis
Western blot analyses were performed using standard protocols and illuminated
with Luminol. Primary antibodies were used at 1: 1000 and horseradish peroxidaseconjugated mouse or rabbit secondary was used at 1: 10,000 (Hetman et aI., 2002).

Immunofluorescence
Deeply anaesthetized rats were transcardially perfused with ice cold PBS
followed by 4% paraformaldehyde in PBS. Following 24 h post-fixation, brains were
cryoprotected for up to 72 h in 30% sucrose and sectioned on a cryostat at 25 /lm
sections, and mounted on slides. Sections were membrane-permeabilized using NP-40
0.5% in PBS. Sections were then incubated in blocking solution (3% bovine serum
albumin, 10% normal goat serum in PBS/O.1 % Triton-Xl 00 (PBST), 1 h) followed by
primary and secondary antibodies (anti-ATM, 1:100, overnight at 4°C and anti-mouseIgG-Alexa-594 or Alexa-488, 1: 100, 1 h at room temperature, respectively).
Immunocytochemistry for cortical neurons was conducted similarly and concentrations as
follows: anti-ATM, 1: 1000, anti-mouse IgG-Alexa-594 or 488, 1: 1000. Nuclei were
visualized by Hoescht-33258. Then, sections were covered with coverslips that were
mounted using Fluoromount G (Southern Biotech, Birmingham, AL, USA).
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RNA isolation and quantitative Real-Time peR
Following CO 2 euthanasia, the entire rat neocortex was harvested and
immediately frozen on dry ice. Tissue RNA extraction was done following
homogenization with a pestle grinder (Fisherbrand; Fisher Scientific, Pittsburgh, PA,
USA) in I mL TRI Reagent (Sigma) at 4°C. Cultured cell RNA was isolated from
5

x

106 cells/sample using TRI Reagent. The random hexamers-primed eDNA synthesis,

quantitative RT-PCR, and the

~~ct-based

analysis of 45S pre-rRNAlI8S rRNA levels

were done as previously described (Pietrzak et aI., 20IIb).

Oligonucleotides
Primers for rat 45S pre-rRNA and 18S rRNA have been described previously
(Pietrzak et aI., 20Ilb). Rat and mouse I8S rRNA share sequence homology. Primers for
mouse pre-rRNA were as follows:
45S forward: 5'-CTC ACC CCC GGT TTG TCC T-3'; reverse: 5'-CTA CCT GGC AGG
ATC AAC CA-3'

18S forward: 5'-TCA ACT TTC GAT GGT AGT CGC CGT-3'; reverse: 5'-TTC TTG
GAT GTG GTA GCC GTT TCT-3'

Primers for human pre-rRN A and 18S rRNA were as follows:
45S forward: 5'-GTC AGC CCT CGA CAC AAG G-3'; reverse: 5'-GGG AGG AAG
ACG AAC GGA AG-3'

I8S forward: 5'-TCA ACT TTC GAT GGT AGT CGC CGT-3'; reverse: 5'-TTC TTG
GAT GTG GTA GCC GTT TCT-3'
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Results

DNA topoisomerase-II inhibitors induce nucleolar transcription through the activation

ofATM
Etoposide is a widely-used anti-cancer drug that inhibits DNA-topoisomerase-2
(Top02) and thereby induces DSBs, SSBs and Top02-DNA cross-links (Nitiss, 2009a).
Etoposide has previously been shown to suppress Poll-mediated transcription at high
concentrations in mouse embryonic fibroblasts (MEFs) (Kruhlak et aI., 2007). Similarly,
etoposide induces nucleolar stress in neurons at concentrations exceeding 10

~M

for 8 h

(Pietrzak et aI., 20 11 b). While evaluating effects of lower concentrations of etoposide we
were surprised to observe stimulation of Poll. Thus, levels ofpre-rRNA increased in
cortical neurons exposed to 0.3 and 1 ~M etoposide for 4 h (Fig. 9A). This finding led us
to test another Top02 inhibitor, ICRF-193, whose potential to induce DNA strand breaks
is lower than that of etoposide (Hajji et aI., 2003; Park and Avraham, 2006; Robinson et
aI., 2007; Nitiss, 2009b). Increased pre-rRNA levels were observed in cortical neurons
that were exposed to 25

~M

ICRF-193 for 4 h (Fig. 9B). We observed a similar

induction of Poll-mediated transcription in the ipsilateral cortices of neonate rats at 4 h
after low dose injections of etoposide or ICRF-193 into a lateral ventricle (Fig. 9C, D).
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Figure 9: Topoisomerase-II inhibitors increase neuronal nucleolar transcription.
A-B, Cultured cortical neurons were treated as indicated for 4 h. (A) Low concentrations
of etoposide increased the 45S pre-rRNAl18S rRNA ratio. Nucleolar transcription was
suppressed at concentrations above 10 )-lM. (B) Increased levels of 45S pre-rRNA after
treatment with 25 )-lM ICRF-193. C-D, P7 rat pups (3 animals/condition) received
injections of either etoposide (C), or ICRF-193 (D) into the right lateral ventricle; after 4
h, ipsilateral cortices were dissected and analyzed. In all graphs, error bars indicate
SEM; *, p<O.05; **, p<O.Ol; in A-B, three independent cultures were analyzed.

57

As in non-neuronal systems, both etoposide and ICRF-193 activate DNA damage
signaling including ATM. We wondered whether activation of Poll in neurons treated
with these drugs is regulated by ATM. First, we confirmed that 1 and 10 flM etoposide
(Fig. lOA), as well as 10 and 25 flM ICRF-193 (Fig. lOB), increased ATM
autophosphorylation at S 1981 suggesting activation of this kinase. Importantly,
concentrations that caused A TM activation overlapped with those activating Poll. We
then used the ATM-specific inhibitor (Hickson et aI., 2004; Li and Yang, 2010),
KU55933 (K5), to test the Poll effects ofTop2 inhibitors upon blocking ATM. At 10
flM, K5 suppressed the etoposide-induced autophosphorylation of ATM at S 1981 (Fig.
1OC). It also suppressed Poll activation either by etoposide (1 flM) (Fig. lOD) or ICRF193 (25 flM) (Fig. lOE). Finally, the etoposide-mediated induction of Poll-driven
transcription in the nucleolus and its prevention by the ATM inhibitor were confirmed
using in situ run-on assay with the RNA precursor, 5-ethynyluridine (5-EU) followed by
immunostaining for the nucleolar marker B23 (Fig. 10F,G). These results also confirmed
that at low concentrations of etoposide which activated Poll, nucleolar integrity was not
affected. Together, these observations suggest that in Top02-inhibited neurons ATM
activation stimulates Poll-driven transcription.
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Figure 10: Poll-mediated transcription of cultured cortical neurons increases in
response to ATM activation by Topo2 inhibitors.
A-B, Etoposide and ICRF-193 activated ATM as indicated by its increased
autophosphorylation at the S 1981 residue. C, The specific ATM inhibitor, KU55933
(K5), attenuated the etoposide-mediated activation of ATM. (A-C) representative
Western blots are shown. Equal protein content on the blots was ensured by reprobing
them for either total MAP2, or running a new gel with the equal protein concentrations
and probing for AKT. D-E, ATM inhibition with 10 11M K5 attenuated the effects of
Top02 blockers on neuronal nucleolar transcription. Averages of3 independent
experiments are shown. F-G, Etoposide-mediated accumulation of nascent RNA in the
nucleolus is prevented by K5. Increased nascent RNA levels in neuronal nuclei were
observed after etoposide treatment, and were reduced following ATM inhibition.
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Cortical neurons were treated with vehicle, 1 11M etoposide, or co-treated with etoposide
1 11M and 10 11M KS for 3 h followed by 1 h incubation with the RNA precursor Sethynyluridine (S-EU, 1 mM). After fixation and co-immunofluorescence for the
nucleolar marker B23, nascent RNA was visualized using "click" chemistry (see methods
for more details). Etoposide increased the ratio between nucleolar- and nuclear- nascent
RNA levels, whereas KS abolished that effect. For nascent RNA quantifications, the
nucleolar compartment was defined by B23 immunofluorescence. (G) Data are averages
of at least 40 randomly selected individual neurons/condition from 3 independent
experiments. In all graphs, error bars indicate SEM; *, p<O.OS; **, p<O.O 1.

The role ofATM in maintaining neuronal Poll activity under basal conditions
To further evaluate the involvement of ATM in regulating nucleolar transcription
in neurons, we first characterized effects of its pharmacological inhibitor KS on other
signaling pathways that were previously implicated in activation of Poll in response to
growth factors. We treated dissociated cortical neurons for 4 h with KS as well as
inhibitors ofERK1I2- (UOI26), PI3K- (LY29004, (LY)), and mTOR- (KU0063794,
(K006)) pathways. We then evaluated the activation status ofERK1I2, and mTORcl by
monitoring phosphorylations ofERK1I2 and RPS6 (T183/YI8S, S23S/236, respectively).
In addition, phosphorylation of AKT at S473 was studied as it may be carried out by
ATM itself or by DNA-PK or mTORc2 (Fig. lIA). Basal ATM inhibition did not affect
ERK1I2, and decreased the phosphorylation of AKT, and RPS6 compared to vehicle.
These results support the notion that ATM contributes to signaling networks that mediate
growth factor responses. Consistent with that, ATM inhibition reduced basal pre-rRNA
levels to a similar extent as did inhibition of ERK 112 , PI3K, and mTOR (Fig. lIB). In
addition, intracerebroventricular injection ofKS reduced basal pre-rRNA levels in the
ipsilateral cortex of neonate rats (Fig. 11 C). To identify whether ATM inhibition
affected global transcription, we again employed the in situ run-on assay to label de novo
transcripts following 4 h treatment with KS (10 11M). Decreased content of nascent RNA
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was observed in neuronal nucleoli in response to ATM inhibition (Fig. 11 D). The
decreased ratio between nucleolar- and total nuclear nascent RNA levels suggests the
anti-transcriptional effects ofK5 were relatively greater in the nucleolus (Fig. lIE). In
concert with prior observations that A TM is concentrated in the nucleoli of human
neurons (Gorodetsky et aI., 2007), ATM immunofluorescence co-localized with the
nucleolar sites of nascent RNA accumulation (Fig. IIF). Finally, lower pre-rRNA levels
were also observed in the cerebella of 5 week old ATM-1- mice (Fig. 11 G). Together,
these findings indicate that ATM regulates Poll, not only upon challenge with DNA
double strand breaks, but also under basal conditions. Such effects may be related to
ATM's contribution to the signaling networks in control of cell growth.
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Figure 11: ATM regulates neuronal Poll under basal conditions
A , Cortical neurons were treated with K5 as well as inhibitors of several well established

signaling pathways that control neuronal growth and mediate effects of growth factors on
ribosomal biogenesis, including ERKl /2, (U0126 at 50 flM) ; AKT (LY294002 at 30
flM) ; mTOR, (KU 0063794, (K006) at 0.3 flM)) , and K5 (10 flM). Their effects on
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phosphorylation ofERK1I2, AKT, and RPS6 were revealed by Western blotting (pT183NI85, ERK1I2; p-S473, AKT; p-S235/236, RPS6). While K5 did not affect
ERK1I2 activity, it did reduce phosphorylations of AKT and RPS6 phosphorylation
suggesting that at least in developing neurons ATM plays a role in growth factor
signaling. B, Cortical neurons were treated with inhibitors as in A. All drugs lowered
pre-rRNA levels. Averages of 3 independent experiments are shown. C, P7 rat pups (3
animals/condition) received injections ofK5 (10 nmoles) into the right lateral ventricle;
after 4 h, pre-rRNA levels in the ipsilateral cortex declined. D-E, Decreased nascent
RNA levels in neuronal nuclei after K5 treatment. (D) Cortical neurons were treated with
K5 (lO/-lM) or vehicle followed by incubation with the RNA precursor 5-ethynyluridine
(5-EU, 1 mM) for 1 h. After fixation and co-immunofluorescence for the nucleolar
marker B23, nascent RNA was visualized using "click" chemistry. (E) K5 decreased the
ratio between nucleolar- and nuclear nascent RNA levels. Data are averages of at least
40 randomly selected individual neurons/condition from 3 independent experiments. F,
ATM co localizes with 5-EU in the nucleolus. G, Decreased pre-rRNA levels in the
cerebellum of 5-week old ATM-1- mice. H, Representative mouse IgG control
immunostaining showing only Hoescht-33258 (blue). In all graphs the averages of3
independent experiments are shown, error bars indicate SEM; *, p<0.05; **, p<O.Ol; ***,
p<O.OOl.

ATM's contributions to the activation of neuronal Poll by BDNF and increased
synaptic activity
BDNF provides an extracellular signal that stimulates neuronal growth by
increasing Poll activity (Gomes et aI., 2011). Therefore, we wondered whether ATM
played a role in BDNF-mediated activation of Poll. In cultured cortical neurons treated
with 10 ng/ml BDNF for 4 h, the activation of growth promoting signaling pathways
including ERK1I2, AKT and mTORcl was indicated by increased phosphorylation levels
ofT183N185, S473 and S235/236, respectively. Activation ofERK1I2 was unaffected
by K5. Conversely, K5 prevented AKT activation and reduced mTORcl activity towards
RPS6. However, K5 interference with mTORcl activation was weaker than that of the
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PI3K inhibitor, LY, or the mTOR inhibitor, KU006 (Fig. 12A). These results suggest a
contribution by ATM to the growth promoting signaling network activated by BDNF.
To determine effects ofK5 on BDNF-induced activation of Poll , two BDNF
stimulation conditions were tested. These paradigms included 2 h BDNF treatment in
full growth medium or 2 h BDNF treatment in trophic deprivation medium, which was
added to cells 2 h before the BDNF addition. The latter paradigm was used to clearly
separate K5 effects on the BDNF response from those of trophic factors that are present
in full growth medium. Indeed, such factors may employ ATM to stimulate Poll as K5
lowered pre-rRNA levels in full media, but not in trophic deprived neurons (Fig. 12B, C).
However, BDNF induced nucleolar transcription under both stimulation conditions, while
K5 reduced the BDNF responses (Fig 12B, C). Similar reductions were also observed
under inhibition ofPI3K and mTOR. Finally, K5 reduced elevated accumulation of
nascent RNA in the nucleoli ofBDNF-stimulated neurons (Fig. 12D). Taken together,
these data suggest that in addition to those PI3K family members that are well established
regulators of neuronal growth, A TM is critical for the activation of Poll in a growthdriving response to BDNF.
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Figure 12: Activation of Poll in BDNF-stiroulated neurons is dependent on ATM,
PI3K and roTOR.
A , Treatment of cortical neurons with BDNF (1 OnglmL) for 4 h increased
phosphorylations ofERK1I2 (T1831Y185), AKT (S473) and RPS6 (S235/236)
suggesting activation ofERK1I2, PI3K1AKT and PI3K1mTORc1 , respectively. ERKI /2
activation was not attenuated by inhibiting ATM (K5), PI3K (LY) or mTOR (K006).
However each of these inhibitors reduced AKT- and mTORcl activation. Although K5
prevented AKT activation, its inhibitory effects on BDNF-mediated activation of
mTORcl were smaller as compared to LY or KU006. B-C, BDNF activation of Poll
was ATM-dependent. Cortical neurons were treated with BDNF for 2 h as indicated.
Inhibition of ATM, PI3K or mTOR prevented BDNF-induced increases ofpre-rRNA
levels. Data are from three independent experiments. D , Co-treatment ofBDNF and K5
decreased nascent RNA levels in neuronal nuclei. Cortical neurons were treated with
vehicle or with BDNF in the presence and absence of K5 (10 )lM) followed by incubation
with the RNA precursor 5-ethynyluridine (5-EU, 1 mM) for 1 hr, as in Figure 11.
Quantifications are averages of at least 40 randomly selected individual
neurons/condition from 3 independent experiments. In all graphs, error bars indicate
SEM; *, p<0.05 ; **, p<O.O I ; ***, p<O.OOl.

As synaptic activity also stimulates neuronal growth, we examined whether it
regulates Poll through the ATM pathway. To stimulate synaptic activity, cultured
cortical neurons were treated for 4 h with SR95531 (Gabazine), a y-aminobutyric acid A
(GABA A) receptor antagonist, and 4-aminopyridine, a selective potassium channel
blocker (Kvl). Confirming prior reports that such treatment stimulates synaptic activity
and increases ERK1I2 signaling (Ghosh and Greenberg, 1995; Krapivinsky et ai., 2003),
we observed increased phosphorylation ofERK1I2 that was unaffected by K5 (Fig. 13A).
Therefore, K5 did not interfere with the neuroexcitatory effects of Gabazine/4AP.
However, it did block the Gabazine/4AP-mediated induction of Poll (Fig. 13B). This
inhibitory effect was similar to that of the ERK1I2 pathway inhibitor, U0126, and the
electrical activity inhibitor, tetrodotoxin (TTX), and the NMDA receptor antagonist,
MK801. These data suggest that enhanced synaptic activity stimulates Poll-driven
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transcription in an ATM-dependent manner. Hence, ATM is a critical transducer for the
growth-associated activation of nucleolar transcription in response to such growth
promoting stimuli as BDNF and synaptic activity.
Figure 13
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Figure 13: Enhanced synaptic activity potentiates neuronal nucleolar transcription
via ERK1I2 and ATM.
A , DIV 8 cortical neurons were treated with the GABA A receptor antagonist, Gabazine
(Gaba) and voltage-gated potassium channel blocker, 4-aminopyridine (4-AP) for 4 h.
This treatment activated ERK1I2. B, Enhanced synaptic activity drove neuronal
nucleolar transcription through an ERK1I2 and ATM dependent pathway. DIV 8 cortical
neurons were treated with inhibitors as indicated. 20 minutes later they were treated with
Gaba and 4-AP or vehicle for 4 h. As anticipated, the sodium channel blocker,
tetrodotoxin (TTX), and MK80 I attenuated the neuronal nucleolar transcription induction
following Gaba/4-AP treatment. Similarly, ERK1I2 inhibition and A TM inhibition in the
presence of Gaba/4-AP also attenuated the transcriptional induction. In all graphs the
averages of3 independent experiments are shown, error bars indicate SEM; *, p<0.05 ;
**, p<O.Ol ; ***, p<O.OOl.
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Inhibition of ATM reduces neuronal growth
To test whether ATM is required for neuronal growth we transfected cortical
neurons with an expression vector for RFP to label cell bodies and neurites of a few cells
(14A) . After 24 h, pharmacological inhibitors of ATM or mTOR were added for the next
24 h. To exclude possible interference of negative survival effects of such inhibitors with
their potential anti-growth actions, a fraction of the transfected (i.e. RFP-positive) cells
with "healthy," non-condensed morphology of nuclear chromatin were determined
following nuclear counterstaining with Hoechst33258 . None of the inhibitors
significantly affected neuronal survival (Fig. l4B) . Conversely, total neurite length
decreased in both ATM- and mTOR-inhibited neurons (Fig. 14C). Although the neuritic
branching was unchanged, as was the number of primary dendrites (Fig. l4D-E), the
Sholl analysis indicated decreased neurite complexity following ATM or mTOR
inhibition (Fig. 14F). In neurons that were stimulated with BDNF, the growth response
to this neurotrophin was also sensitive to ATM or mTOR inhibitor (Fig. 15). Under
BDNF-stimulated conditions, the K5 inhibitor did not affect neuronal survival (Fig. 15B).
However, it significantly attenuated BDNF-mediated increases in dendrite total length
and the number of primary dendrites (Fig. 15C). In addition, BDNF-mediated increases
in dendritic length, branching and overall complexity were attenuated by ATM inhibition
as revealed by the Scholl analysis (Fig 15F). Collectively, these results suggest that in
addition to mTOR, ATM is a major regulator of neuronal growth. Such a notion is
consistent with a critical role of either pathway in driving neuronal production of
ribosomes.
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Figure 14: Pharmacological inhibitor of ATM reduced neurite length and neurite
complexity under basal conditions.
Cortical neurons were transfected on DIV 3 with an RFP expression vector (0.25 ~g
5
plasmid DNAl5 X 10 cells) . Treatments with a vehicle (Veh, 0.2%DMSO), 10 ~M K5
or 0.3 ~M K006 were initiated on DIV4 and continued for 24 h. A , Representative
photomicrographs of individual transfected neurons following the inhibitor treatment. BF , Morphometric analysis of ATM- or mTOR-inhibited neurons. ATM or mTOR
inhibition for 24 h had no significant effects on cell survival as determined by the fraction
ofRFP-positive neurons with a " healthy," non-condensed chromatin that was visualized
by counterstaining with Hoechst33258 . Both inhibitors reduced total neurite length (C)
without affecting neuritic branching (D) or the number of primary dendrites (E).
However, Scholl analysis indicated reduced neuritic complexity following treatment with
either inhibitor. The effect of the A TM inhibitor was mainly on the distal neurites while
the mTOR inhibitor affected more proximal processes (F) . (B-F), data are from a
minimum of 36 cells per condition that were analyzed in three independent experiments,
error bars indicate SEM; *, p<0.05; ** , p<O.Ol ; *** , p<O.OOl.

69

Figure 15
A

B

C

BDNF

0

co

0.8

>

0.4

::>

0.2

.~

'"

co ~ 1200
- E
-; 2; 900

0.6

o

OJ.s::

"' -

~ OJ
.,
c
> .,
co-

o

BDNF" KS

m rr

600

0

24 hours

'"
.Sl
·c

.,:>c

0

c-

S

m

~

co
·c

E

~ .§

.,.,

BDNF

10

~ ~ O.S
-5~
c co

0

~

E

~
.~'"
.- ::>

300

II>

BDNF

0

BDNF

lSoo

~

BDNF

c-

0

0

~

0

0

II>

0

~

24 hours

24 hours

0

II>
~

24 hours

F
10
8

'"g>6

·iii

'"
<.)

e4

.

Veh

.

BDNF

_ BDNF+KS
2
0

10

100

150

Radius (flm)

Figure 15: Pharmacological inhibitor of ATM reduced neurite length and neurite
complexity in response to BDNF-stimulated growth
Cortical neurons were transfected on DIY 3 with an RFP expression vector (0.25 I1g
plasmid DNA/5 X 10 5 cells). Treatments with vehicle (Veh, 0.2% DMSO), BDNF (20
ng/mL), and BDNF plus inhibitor: 10 11M K5 treated on DIV4 and continued for 24 h. A ,
Representative photomicrographs of individual transfected neurons following the
indicated pharmacological treatment. B-F, Morphometric analysis of BDNF-stimulated
ATM- or mTOR-inhibited neurons. (B) ATM inhibition in the presence ofBDNF for 24
h had no significant effects on cell survival as determined by the fraction ofRFP-positive
neurons with a "healthy," non-condensed chromatin that was visualized by
counterstaining with Hoechst33258 . ATM inhibition reduced total dendritic length (C),
did not significantly affect neuritic branching (D), but did attenuate the number of
primary dendrites (E). Scholl analysis indicated reduced neuritic complexity following
K5 treatment (F) . In B-F, data are from a mean of 36 cells per condition that were
analyzed in three independent experiments, error bars indicate SEM; *, p<0.05 ; **,
p<O.Ol ; *** , p<O.OOl.
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ATM-mediated regulation of Poll in dividing cells
To test the possibility that ATM regulates Poll activity in proliferating cells, we
perfonned serum stimulations of the human neuroblastoma SH-SY5Y cell line and
human cervical cancer HeLa cell line with or without the ATM inhibitor. Under such
conditions, serum mediated induction ofpre-rRNA expression was abolished in SHSY5Y cells (Fig. 16A). In HeLa cells K5 reduced the serum-mediated increase in prerRNA levels by 59% (Fig. 16C). These observations suggest that ATM is required for
ribosomal biogenesis not only in rodent neurons but also in dividing human cancer cell
lines.
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Figure 16: Requirement of ATM for serum-mediated activation of Poll in dividing
human cell lines.
A-C, After overnight serum deprivation of human SH-SY5Y neuroblastoma cells (SH5Y) or HeLa cervical cancer cells (HeLa), restoration of the full growth medium that
contained 10% FBS activated Poll as suggested by increased pre-rRNA levels at 4 h after
starting such stimulation. Poll activation was reduced in the presence of the ATM
inhibitor K5 (10 11M). (A) The average of3 independent experiments are shown. (B)
Data from a representative experiment; (C) the mean percent of the serum-mediated
increase in pre-rRNA levels from 4 independent HeLa cell experiments is depicted. In all
graphs, error bars indicate SEM; **, p<O.Ol; ***, p<O.OOl.
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Discussion

We report that Poll-driven transcription, the rate-limiting step of ribosomal
biogenesis, is regulated by ATM in both postmitotic neurons and in dividing cells. In
primary neurons exposed to low level DNA damage, BDNF or enhanced synaptic
activity, ATM was necessary for increases in Poll activity. In human cell lines of tumor
origin, ATM was essential for Poll activation by serum. In addition, A TM inhibition
reduced BDNF-stimulated neurite outgrowth. Collectively, ATM appears to be a major
regulator of neuronal growth with at least one of its growth promoting mechanisms being
stimulation of nucleolar transcription.

The effects of ATM inhibition on ribosomal biogenesis and neuronal growth are
similar to those affected by interference with the ERK1I2- or the mTOR signaling
pathways. In cultured neurons, ATM inhibition reduced activity of the PI3K1AKT and
the PI3K1mTOR pathways without affecting ERK1I2. As PI3K1mTOR signaling
regulates Poll and is essential for neuronal growth, pro-ribosomal and pro-growth effects
of ATM may be due to its role in activation ofmTOR. Indeed, ATM has been implicated
as a growth factor-stimulated kinase for AKT on residue S473 which by activating AKT
could regulate mTOR. Alternatively, being somewhat similar to mTOR, ATM could
offer a parallel pathway that would be activated by similar upstream mechanisms and
target similar downstream substrates. In support of these notions, the principal activator
ofmTOR, Rheb, can also interact with ATM (Long et aI., 2005). Similarly, 4E-BP has
been shown as a common substrate for both kinases (Yang and Kastan, 2000; Hannan et
aI.,2003). In neurons ATM is found in the cytoplasm, at the membrane, in neurites and
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in the nucleolus. As such, it may interact with both mTOR activators and a wide
spectrum of critical pro-growth substrates of that pathway. Finally, the ATM localization
to the nucleolus may offer a unique position to regulate ribosomal production. While at
least two nucleolar regulators of that process including nucleophosmin and nucleolin
have been shown to be direct substrates of ATM (Nalabothula et aI., 2010), the impact of
their ATM-mediated phosphorylations on Poll activity remains to be determined.

We previously identified Poll as a major neuronal growth effector for the BDNFactivated ERK1I2 pathway (Gomes et aI., 2011). Therefore, it is tempting to speculate
that Poll may be equally important for the neuronal growth regulation by other growth
promoting pathways such as mTOR or ATM. Conversely, there may be additional
mechanisms by which these kinases promote neuronal growth. Such mechanisms may
include regulation of neuronal cytoskeleton and stimulation of local protein synthesis.
Relative contributions of ribosomal biogenesis, translational regulation and cytoskeletal
dynamics to the A TM effects on neuronal growth are to be determined.

Autophosphorylation of ATM on S 1981 is a well-established indicator of its
activation by DNA damage or oxidative stress (Bakkenist and Kastan, 2003; So et aI.,
2009; Guo et aI., 2010a). It was also observed during retinoic acid- (RA) induced
differentiation ofSH-SY5Y neuroblastoma cells (Fernandes et aI., 2007). However, no
evidence for S 1981 autophosphorylation has been presented in a paradigm of insulinmediated activation of ATM (Yang and Kastan, 2000). Similarly, while neuronal ATM
was strongly autophosphorylated in response to Top02 inhibition, no change in pS 1981
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levels could be detected after BDNF stimulation or enhancement of synaptic activity
(data not shown). Therefore, growth-promoting signals may activate ATM via
alternative mechanisms that do not involve its autophosphorylation at S 1981. Our future
studies will address these mechanisms, including the possibility that neurotrophic factoractivated small GTPases, such as Rheb, activate ATM in the absence of DNA damage.

There is growing evidence that reduced ribosomal biogenesis contributes to
neurodegeneration. For instance, inducible disruption of Poll activity by knocking out its
co-activator TIF -1 A in mature mouse neurons resulted in degeneration of various
neuronal populations including cortical and hippocampal neurons, striatal neurons and
substantia nigra neurons. In the latter system, Poll inhibition also led to oxidative stress.
Partial insufficiency of neuronal nucleolar transcription has been demonstrated in
Alzheimer's disease and associated with increased oxidation of rRNA and ribosomal
failure (Ding et aI., 2005). Such effects were also observed at the early stages of AD
(Ding et aI., 2006). Interestingly, iron-catalyzed Fenton reactions have been proposed as
a primary source ofrRNA damage in AD brains (Honda et aI., 2005). In addition,
degeneration of striatal neurons in Huntington's disease has been associated with HDlinked mutations in hunting tin that directly block the Poll-specific transcriptional
regulator, UBF (Lee et aI., 2011). Therefore, it is tempting to speculate that A-Tassociated neurodegeneration, which is accompanied by oxidative stress and attenuated
by iron complexing, may be at least in part due to insufficient ribosomal biogenesis.
Such insufficiency could slow the rate of replacement of damaged ribosomes, reduce
protein synthesis capacity, and trigger neuronal atrophy and degeneration. Our future
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studies will evaluate whether nucleolar impainnent contributes to neurodegeneration in
A-T.
In addition to neurodegeneration, A-T patients suffer immune deficits, and
demonstrate retarded growth and accelerated aging. At least some of these defects were
associated with reduced proliferation of ATM-deficient cells. We found that in addition
to neurons, ATM regulated Poll-mediated transcription in proliferating cells.
Intriguingly, Poll activity is a critical regulator of cell growth and division (Drygin et aI.,
2010). In fact, Poll is the major effector for such principle cell cycle driver as c-Myc.
Unsurprisingly, in most cases of oncogenic transfonnation, Poll activity is deregulated
by loss of function mutations in tumor suppressor genes, or gain of function mutations in
oncogenes (Drygin et aI., 2010). Interestingly, reduced proliferation and premature
senescence in ATM-null mouse fibroblasts is rescued by inhibiting the nucleolar sensor
protein and a negative regulator of ribosomal biogenesis, pl9

ARF

(Kamijo et aI., 1999).

Thus, it is likely that insufficient ribosomal biogenesis may account for the growth
defects of A-T cells, thereby contributing to at least some non-neurological symptoms of
that disease. Finally, blocking A TM may offer yet another strategy to block tumor
growth by interfering with ribosomal biogenesis.

Collectively, we demonstrate a new role of ATM in the regulation of ribosomal
biogenesis and neuronal growth. While such activity goes beyond its well-established
role in the DNA damage response, this function fits well with its similarities to the
growth-promoting members of the PI3K family, including PI3K and mTOR. Therefore,
one may consider that functional specialization of the members of this family is not
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absolute. Rather, functional redundancies and/or mutual regulatory connections between
PI3K family members contribute to the integration of information about genome
integrity, nutrient availability and growth factor exposure.
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CHAPTER IV
DISCUSSION

Restatement of the key findings
These studies concentrated on describing the regulation of Poll-mediated
transcription in neurons. In Chapter II, I reported that etoposide treatment suppressed
Poll transcription and disrupted nucleolar integrity in cortical and hippocampal neurons
of whole rats irrespective of developmental stage. However, in the developing, but not
the mature brain, etoposide induced apoptosis. Additionally, other experiments
performed in the Hetman laboratory in connection with these studies have demonstrated
that in etoposide-treated neurons SSBs and/or protein DNA adducts provided the main
interference with Poll, while DSBs were the main trigger for apoptosis (Pietrzak et ai.,
20 II b). Taken together these findings suggest that the nucleolus may playa role of a
genomic integrity sensor in both young and adult neurons. In addition, they suggest that
the aging- or neurodegeneration-associated accumulation of SSBs or large DNA adducts
may disrupt ribosomal biogenesis thus compromising protein synthesis and leading to
neuronal atrophy.
In Chapter III, I report the identification of A TM as a novel regulator of Pollmediated transcription in postmitotic neurons and in proliferating cell lines. These
findings suggest that reduced production of ribosomes may contribute to the A-Tassociated neurodegeneration and impairment of cellular proliferation. Therefore, in
addition to being a DNA repair disorder, A-T may also be a ribosomal disease.
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Collectively, these findings suggest that Poll-mediated transcription is a target for the
neurodegeneration associated forms of DNA damage including SSB and DNA adducts
and the neurodegeneration-inducing deficiencies in ATM signaling.

Limitations and alternative interpretations

In Chapter II, etoposide was injected directly into the lateral ventricle of neonate
rats, while in the adult rats the delivery was via the intracarotid artery. These different
methods of delivery required different doses (Maeda et aI., 1999). Though I witnessed
comparable effects on the activity of nucleolar transcription and nucleolar disruption in
both treatments, one may question whether these two methods are comparable.
Etoposide delivery via the intracarotid artery following blood brain barrier disruption has
been used in the clinic (Madajewicz et aI., 1991), but this method may affect other
systems upon delivery. The toxicity evaluations of humans treated with etoposide via the
intracarotid artery indicated only neurological effects on few patients and hematomas at
injection sites (Madajewicz et aI., 1991). In adult rats treated through the intracarotid
artery, etoposide caused hypo activity and slowed breathing 5 h after treatment.
Conversely, neonate rats treated with etoposide directly to the lateral ventricle were
nursing within 1 h after treatment and survived up to 72 h after treatment. Unfortunately,
adult rat longevity post-treatment was not evaluated beyond 6 h. However, a decreased
dose of 5 mglkg delivered via the intracarotid artery allowed survival up to 72 h.
Hypoactivity and slowed respiration was witnessed under this treatment condition for up
to 2 h after treatment, however nucleolar disruption was not noted microscopically in
either of 2 animals treated with this dose. These findings are consistent with the lack of
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biological effect observed by other researchers with a dose of 3 mg/kg delivered through
the intracarotid artery (Maeda et ai., 1999). Conversely, the dose delivered to the
neonates caused neuronal nucleolar stress and apoptosis. Data from etoposide treatment

in vitro may offer an explanation as to the lack of nucleolar effect after 5 mg/kg of
etoposide treatment in vivo. Doses of etoposide treatment below 25 11M were unable to
cause nucleolar transcription in cultured neonate cortical neurons. Instead, treatments
below this concentration caused apoptosis, while the higher doses of etoposide, which
induced more SSBs and DNA-Top02 adducts caused nucleolar stress (Pietrzak et ai.,

2011 b). Upon intracarotid delivery some drug is likely taken up by the arterial
endothelium, and is relatively diffused by its path throughout the ipsilateral hemisphere,
while delivery to the ventricle concentrates the treatment to a relatively smaller area.
Further, the osmotic disruption of the blood brain barrier increases drug delivery
efficiency, but remains less efficient for drug delivery than ICV delivery. These elements
likely support the in vivo absence of nucleolar stress following 5 mg/kg doses of
etoposide in the adult. As the biological effect on the nucleolus was comparable between
intracarotid delivery of 15 mg/kg and ICV neonate delivery of 10 nmoles, in terms of
Poll suppression and observed cell frequency (i.e., all cells), the doses are likely
comparable despite different systems of delivery.

NPM/B23 translocation to the nucleoplasm occurred in all analyzed cells
following 15 mg/kg of etoposide delivery to the adult rat brain, yet apoptosis was absent,
which may suggest a neuronal protective threshold, rather than absence of biological
effect. Instead, the absence of apoptosis is a function of neuronal maturation. Adult
neurogenesis cannot replace all neurons in the brain, thus longevity of adult neurons is
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required. Therefore, with increasing age, neuronal protection from apoptosis gradually
becomes the default setting, whereas prior to maturity apoptosis was the default setting.
Embryonic day 15-16 mouse cortical neurons maintained in culture for 25 days have a
reduced apoptotic response following etoposide treatment than do like-treated neurons
cultured for 5 days. This effect is partially associated with the reduction of p53responsiveness in 25-day cultured neurons compared to 5-day cultured neurons (Martin et
aI., 2009), and the nearly complete reduction of 5-day cultured apoptosis in p53-1- neurons
compared to the remaining apoptotic response in 25-day cultured p53-1- neurons. These
results suggest that p53-mediated apoptosis in response to DNA damage decreases with
increasing neuronal age (Martin et aI., 2009). Further, the tyrosine kinase c-Abl, binds
p53 in response to DNA damage and suppresses apoptosis in mature neurons and its
deletion is protective in immature neurons (Martin et aI., 2009).
The increased threshold to apoptosis is at least partially attributed to the reduction
of pro-apoptotic molecules with increasing age, however increased expression of antiapoptotic molecules can also increase the cellular threshold to apoptosis in mature
neurons (Benn and Woolf, 2004). For instance, such anti-apoptotic mediators are likely
responsible for the neuronal maturation-related delay in the release of cytochrome C
which is a critical step in apoptosis (Wright et aI., 2007). Apafl binds cytochrome C in
the cytosol, and together they form the apoptosome. Apafl expression is suppressed in
mature neurons, thus altering the recruitment of caspases to the apoptosome. Mature
neurons grown in culture are sensitive to etoposide treatment, but at a slower rate than
immature neurons and that change in sensitivity is Apafl-dependent (Wright et aI., 2007;
Vaughn and Deshmukh, 2008). Moreover, endogenous expression of Apafl in mature
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neurons is re-established following DNA damage, and dependent upon the availability of
chromatin to the transcriptional machinery (Wright et aI., 2007; Vaughn and Deshmukh,
2008). It is possible that the increased threshold to apoptosis protected the somas of the
etoposide-treated adult cortical neurons, and that the toxicity was targeted to the neurites,
resulting in the degeneration of the neural processes. Indeed, such notions have been
described earlier following transient ischemia (Fukuda et aI., 1999), endogenous toxicity
in a an amyothrophic lateral sclerosis model (Gould et aI., 2006) and a DNA damage
repair mutant (de Waard et aI., 2010). If true, it is possible that such effects may have
been missed upon morphological evaluation. On the other hand, cleaved caspase-3
staining markedly identified the cytoplasm of cells undergoing apoptosis (Figs. 6, 7). It
is also conceivable that ultrastructural changes were subtle at the 6 h time point for adult
neuron apoptosis. Similarly, only 6 h may have been insufficient time to see mature
neuron death. Indeed, 2S-day cultured neurons acquired fewer DSBs, as determined by
comet assay, compared to S-day cultured neurons after 4 h of etoposide treatment (Martin
et aI., 2009). Further, the susceptibility to DNA damage-mediated apoptosis in mature
neurons is slowed compared to immature neurons, thereby supporting such a notion
(Wright et aI., 2007).

In Chapter III, I used the pharmacological agent KUSS933 (KS) as an inhibitor of ATM
in order to establish ATM's role in ribosomal biogenesis. The selectivity and
functionality of this inhibitor to ATM has been well-established as a competitive ATM
binder (Hickson et aI., 2004; Bryant and Helleday, 2006; Li and Yang, 2010). The
reliance we have placed on KS as an inhibitor of ATM is potentially problematic, but was
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necessary because multiple attempts to knock down ATM using short hairpin RNA
(shRNA) were unsuccessful. KS activity in our cellular system has been identified by the
inhibition of ATM autophosphorylation at S 1981 in response to etoposide treatment, as
indicated by Western blot analysis. The autophosphorylation site S 1981 is not
phosphorylated in response to non-DNA damage-related stimuli such as Gabazine or
BDNF (data not shown). Therefore, ATM inhibition by KS in response to these
stimulations was not identifiable by Western blot, nor was KS inhibition of A TM under
basal conditions. Further, despite published KS specificity to inhibit ATM in cycling
cells, its use in neurons has not been previously reported. As such, KS's specificity to
ATM in our neuronal system has only been assumed. It is therefore possible that KS may
be metabolized in our cellular system in a manner that reduces its specificity to ATM,
thus suggesting that the KS effects on nucleolar transcription could be partly mediated
through signaling pathways that engage relatives of ATM, such as PI3K or mTOR. Both
the PI3K and mTor are known to respond to neurotrophins and neuronal activity.
However, in etoposide-treated neurons, I observed a KS-sensitive induction of rDNA
transcription in the absence of any evidence for PI3K1mTor activation. Furthermore, the
inhibition of mTOR by K006 for 24 h did not have the same effect on neurite outgrowth
as did KS treatment for 24 h. Most importantly, Poll-driven transcriptional impairment
was identified in the cerebellum of ATM-null mutant mice. This finding provided
genetic loss of function data that paralleled Poll-mediated transcriptional responses in
KS-treated neuronal cultures and ICV infusion of KS in the rat neonate neocortex.
Therefore, it is unlikely that KS treatment provided major inhibitory effects on Poll
transcription by a means other than inhibiting A TM in our systems.
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Our work has provided evidence that supports the involvement of ATM in
nucleolar transcription as a far-reaching biological phenomenon. First, the recapitulation
of nucleolar transcription suppression following K5-mediated ATM inhibition in vivo
provides evidence that Poll-mediated transcription in multiple cell types is incomplete
without ATM involvement. As glia make up a significant portion of the neonate brain,
this result suggests that ATM's involvement in nucleolar transcription may not limited to
neurons. Broad biological involvement of A TM in nucleolar transcription is further
evidenced by the work conducted in the HeLa and SHSY-5Y immortalized human cell
lines. The potentiation of Poll-mediated transcription in response to serum
replenishment after serum starvation is attenuated by K5-mediated inhibition of ATM.
The absence of A TM does not cause a complete inhibition of nucleolar transcription, but
rather a reduction compared to basal levels, presumably via redundancy by other
pathways that regulate Poll. ATM deficiency in the cerebellum of 5-week-old ATM-null
mice shows evidence of Poll-mediated transcriptional suppression, while II-week-old
mutant mice show enhanced Poll-mediated transcriptional inhibition (data not shown).
At II-weeks of age the cerebellar Purkinje cells have started to degenerate in the ATMnull mutant mouse lines (Li et aI., 2011). Neurodegeneration is known to stimulate
reactive gliosis (Smith et aI., 20 II). As such, we hypothesized that the increased 45S
rRNA levels were due to reactive glia responding to the neurodegeneration, and therefore
evaluated the levels of glial fibrillary acidic protein (GFAP) at both the 5-week and 11week ages. These results showed that GFAP levels were no different in 5-week ATMnull mice compared to wildtype, but were significantly increased in the II-week old mice
compared to wildtype (data not shown). This may suggest that in the absence of ATM,
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reactive glia were able to increase nucleolar transcriptional presumably using other
pathways such as mTor or ERK1I2. Importantly, it does not suggest that the ATMmediated suppression of Poll is rescued by reactive gliosis, but rather that the increased
growth of dividing cells masks the net effect on Poll.
Activation of A TM is identified by its autophosphorylation at S 1981, the
canonical DNA damage-mediated activation site (Bakkenist and Kastan, 2004). Attempts
to show A TM autophosphorylation at S 1981 following BDNF or synaptic activity
stimulation have been unsuccessful. Though critics may interpret such a finding as
evidence for ATM unresponsiveness to trophic stimuli, an alternative interpretation that
considers other supporting data is that non-DNA damage-related stimuli activate ATM
without affecting auto activity at S 1981. Indeed, ATM has been shown to have multiple
autophosphorylation sites (Kozlov et aI., 2006; Kozlov et aI., 2011). Moreover, evidence
of ATM activation in response to oxidative stress has been shown to be separate from its
activation in response to double-stranded breaks. Indeed, the A TM dimer is activated by
redox reaction in response to oxidative stress instead of by phosphorylation of an ATM
monomer (Guo et aI., 201Oa; Guo et aI., 201Ob).
Due to the involvement of nucleolar transcription in neurite outgrowth (Gomes et
aI., 2011), we assessed the effect of24 h pharmacological inhibition of ATM on neurite
outgrowth in developing neurons in culture compared to vehicle and mTOR inhibition
treatments. Both mTOR and ATM inhibition suppressed neurite outgrowth under basal
conditions. ATM inhibition under BDNF-stimulated conditions also robustly suppressed
neurite outgrowth. These results suggest a downstream biological effect on neurites
following sustained nucleolar transcriptional suppression, and support the notion that
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ATM is a growth-promoting kinase (Yang and Kastan, 2000; Li and Yang, 2010).
However, as ATM has been shown to be involved in insulin signaling and translation
initiation (Yang and Kastan, 2000; Li and Yang, 2010), and mTOR is a well-established
upstream mediator of protein synthesis and cellular growth (Mayer et aI., 2004; Ruvinsky
and Meyuhas, 2006; Swiech et aI., 2008), the ant-growth effects ofKS and K006 may
also involve these additional effectors besides Poll. For instance, 24 h pharmacological
inhibition of ATM and/or mTor may have reduced phosphorylation of 4E-BPI, and thus
decrease translation (Mayer et aI., 2004; Ruvinsky and Meyuhas, 2006). Further, it is
possible that the effects we have witnessed in neurite morphogenesis are the outcome of
changes in cytoskeletal dynamics in response to ATM inhibition mediated through an
interaction with nuclear factor kappa B (NF-KB) (Gutierrez and Davies, 2011; Semlitsch
et aI., 2011).
Result artifacts can stem from the system with which we've been working, despite
having controls in the same system. Harvesting primary cortical neurons requires
trituration to separate cell clumps. This process is an unnatural one, and thus may cause
cellular damage. Further, in order to grow an enriched population of cortical neurons,
glia proliferation must be suppressed. Arabinofuranosyl cytidine (AraC), a genotoxin, is
used to prevent the growth of dividing glia cells in our culture system. Though AraC has
been widely used, including in the Hetman lab, and it does not appear to have negative
effects on neurons at the concentrations used, it may theoretically activate DNA damage
response contributing to the apparent ATM signaling in response to non-genotoxic
stimuli. Perhaps the greatest source of artifact, because of A TM's ability to respond to
oxidative stress, is the non-physiological oxygen/C0 2 conditions of the incubators in

86

which the neuronal cultures were maintained. The 95% air/5% CO2 content may
generate oxygen radicals that activate ATM in a manner that will not induce its
autophosphorylation at S1981, but nonetheless induce ATM activity (Guo et aI., 201Oa;
Guo et aI., 20IOb). These complications imply further importance on the recapitulation
of the key in vitro results in the whole animal. Supporting these in vitro results, we
observed suppressed Poll-mediated transcriptional activity in the Atm-I - cerebella, and in
whole rat neonates after infusion of K5 intracerebroventricularly.

Etoposide as a novel suppressor of neuronal Poll
Etoposide inhibits Top02 causing single-stranded breaks in DNA and DNA-Top02
adducts, as well as double-stranded breaks (Bromberg et aI., 2003; Pietrzak et aI., 2011b).
Oxidative- or energy deprived-mediated cellular stress-derived impairment of nucleolar
transcription can be mediated by JNK2 or AMPK, respectively (Mayer et aI., 2005;
Hoppe et aI., 2009). Genotoxic stress-induced Poll transcriptional inhibition is further
dependent upon the presence of ATM (Kruhlak et aI., 2007), and may also be a response
to physical interference caused by DNA lesions (Hetman et aI., 2010). Regardless of the
mechanistic detail, the transcriptional pause offers an opportunity to conserve energy,
prevent cell cycle entry and growth, and provides an opportunity to respond and perhaps
repair genotoxic damage.
In cycling cells, nucleolar transcription halts and the nucleolus disappears upon
mitotic entry by the phosphorylation ofTAF 111O at T852 by Cdkl-CyclinB (Drygin et
aI., 2010; Grummt, 2010). This phosphorylation impairs the SLl/TIF-lB interaction with
UBF to prevent initiation complex formation. This SLl/TIF-lB - UBF interaction is also
prevented by JNK2 phosphorylation ofTIF-IA at T200 in response to oxidative stress
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(Mayer et aI., 2005). JNK2 signaling to impair nucleolar transcription may be specific to
oxidative or bulky adduct lesions as irradiated JNK2 deficient cycling cells continue to
transcribe rDNA (Kruhlak et aI., 2007). Though DNA damage may cause physical
impairments on DNA that prevents promoter binding (Marietta et aI., 2002) or
transcriptional elongation (Hetman et aI., 2010), irradiation-mediated DNA damage may
cause Poll transcriptional inhibition by the activity of DNA damage repair enzymes such
as ATM (Kruhlak et aI., 2007). While my data does not support the role of ATM as a
suppressor of Poll, a possibility that JNK2 or CDKs play such a role in etoposideexposed nervous system is worth further testing.
Etoposide treatment required high concentrations to suppress Poll-mediated
transcription in cortical neurons cultured from newborn rats, and in neonate and adult
brains. Though we concentrated our analysis on postmitotic neurons, in vivo
immunohistochemical staining ofNPMlB23 suggested that all analyzed cellular nucleoli
were disrupted. This would suggest that at the etoposide concentrations used, the
nucleoli of glia were equally susceptible to nucleolar disruption as were neurons. In
contrast, researchers using wildtype MEFs treated with 20 )lM etoposide showed Pollmediated transcriptional inhibition (Kruhlak et aI., 2007), while Atm-I - MEFs did not.
These results suggest that the response to etoposide is akin to the irradiation response,
even at low concentrations of etoposide (Kruhlak et aI., 2007). Though this may initially
appear like a discrepancy, it would suggest that dividing cells are more susceptible to
genotoxic damage than postmitotic cells, such as neurons. The etoposide concentrations
used in the neonate and adult brain exceeded the threshold for glial transcriptional
inhibition (perhaps around 20 )lM, or in the brain 2 nmoles), whereas postmitotic cells
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required higher concentrations of the single-stranded breaks and bulky adducts for
nucleolar disruption. Therefore, it may be no surprise that our observations could not
identify non-neuronal cells that had completely intact nucleoli. Further, in the neonate,
10 nmoles of etoposide resulted in an incomplete disruption, as evidenced by diffusion of
NPMlB23 in the nucleoplasm with some remaining punctuate staining foci ofNPM/B23
in the nucleolus.

ATM as a novel positive regulator of Poll
It may not be surprising that ATM can influence the activity of Poll given its
downstream influence over the cell cycle in response to double-stranded DNA breaks.
Indeed, Poll-mediated transcription is ongoing in MEFs lacking ATM, and inATMIcells in the presence of irradiation or etoposide treatment, while other DNA damage
signaling kinases are dispensable (Kruhlak et aI., 2007). These data suggest that ATM
transiently inhibits the assembly of the Poll initiation complex following DNA damage
by a yet unknown mechanism, and leads to displacement of elongation enzymes. Within
one hour, MEFs exposed to irradiation or etoposide recovered from Poll-mediated
transcriptional arrest. The activation of ATM is likely mediated by the DNA torsional
strain applied by the induction of bulky adducts by irradiation or etoposide, as ATM is
autophosphorylated by chromatin rearrangement (Bakkenist and Kastan, 2003; Berkovich
et aI., 2007; Iijima et aI., 2008). One may hypothesize that this response is mediated by
JNK2, as the nucleolar stress signaling kinase (Mayer et aI., 2005; Mayer and Grummt,
2005), but in these conditions the nucleolar stress response requires A TM while JNK2 is
dispensable (Kruhlak et aI., 2007). The DNA damage-mediated suppression of Poll and
subsequent nucleolar disruption, which ultimately leads to p53 accumulation, may be an
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important step to promote a p53-ATM interaction with an active ATM to potentiate a
stress response signal transduction cascade.
Data presented herein support the hypothesis that ATM is a regulator of Pollmediated transcription, but in a manner outside the realm of DNA damage signaling.
Kruhlak, et al. suggest that ATM activation impairs Poll transcriptional activity and
ATM deficiency prevents Poll transcriptional suppression. Conversely, data presented
here suggest that ATM is a regular contributor to induce Poll-mediated transcription and
its absence suppresses Poll-mediated transcription when compared to basal levels.
Though this finding may appear to be a contradiction to the Kruhlak, et al. data, upon
further evaluation of that report, it is clear that basal levels of Poll transcription were not
quantified and compared between A TM deficient and control cells. Therefore, it is
possible that in the ATM deficient MEFs and fibroblasts, Poll-mediated transcription
was basally impaired compared to control cells. Continuing in that logic, Poll-mediated
transcription would have remained viable due to canonical Poll regulators, such as
ERK1I2, PI3K and mTOR. Etoposide likely activated ATM in response to Topo2 pause
that causes DNA torsional strain (Bakkenist and Kastan, 2003). The low etoposide dose
(lIlM) and short kinetics (4 h) likely contributed to my ability to detect the induction of
Poll-mediated transcription. It is possible that ATM was immediately and locally
activated in response to the DNA torsional strain, which may have loosened chromatin at
the site of damage either by supercoiling or by recognition of the damage and recruitment
of responding enzymes, such as the MRN complex. Despite the complexities associated
with A TM activation following DNA damage, etoposide may cause dichotomous ATM
behavior depending upon its kinetics and concentration.
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Despite the majority of our work being conducted in cultured, primary neurons
obtained from newborn rats, we extended our findings to the neocortex of rat neonates, as
well as cycling, immortalized human cell lines. Indeed, the basal suppression of Pollmediated transcription in response to ATM inhibition is robust enough to be identified in
RNA extracted from whole brain lysates, of which multiple cell types are present.
Further, these findings were recapitulated in ATM deficient mouse cerebella, the RNA of
which was also extracted from whole cerebellar lysates. The findings herein suggest that
the ATM-mediated contribution to Poll-mediated transcription is ubiquitous. This
suggestion may even be extrapolated to previous reports of A TM being required for
etoposide-mediated nucleolar suppression in MEFs (Kruhlak et aI., 2007). Had these
researchers been evaluating nucleolar transcription following a detailed etoposide dose
response, they may have also witnessed the finding we report herein. However, the Pollmediated suppression response to ATM deficiency can be masked by other signaling
pathways that contribute to Poll-mediated transcriptional activity. An example of this
masking can be taken from the glial response to neurodegeneration in ATM-deficient
mice. Growth is required by glial cells to fill in the tissue gaps created by atrophying
neurites. The stimulation of Poll-mediated transcription by PI3K1mTOR and/or ERKMAPK is sufficient to stimulate growth, but would be less stimulatory to Poll
transcription than an equally reactive gliosis in ATM wildtype brain that also had
PI3K1mTOR and/or ERK-MAPK input. The ATM input, therefore, may also be growthrelated, and thus have an upstream activator sufficient to provide such growth-stimulated
input.
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Great progress has been accomplished in recent years in identifying the DNA
damage-mediated activation of ATM. Relaxation of chromatin appears to be the
activating stimulus of ATM, which is a homodimer prior to autophosphorylation at
Sl981 (Bakkenist and Kastan, 2003). Despite the presence of numerous DNA damageinitiated autophosphorylations (Kozlov et aI., 2011), once autophosphorylated at S 1981
the dimerized A TM dissociates and its monomers are recruited to the sites of damage.
The dimerized form of A TM is integral for its capacity to signal in response to oxidative
stress (Guo et aI., 2010b). ATM oxidation causes formation ofa disulfide bond crosslinker at a specific cysteine (C2991) between the two monomers, yet the responsiveness
of ATM to DNA damage is unaffected by site-directed mutagenesis ofC2991 (Guo et aI.,
201 Ob). We have observed that S 1981 autophosphorylation is absent in synaptic activity, or BDNF-stimulated neurons (data not shown), yet ATM inhibition suppresses the Pollmediated transcriptional drive associated with these processes. This suggests that ATM
could be a dimer in regulating nucleolar transcription. Further support for this possibility
comes from the basal levels of nucleolar transcription that are impaired upon ATM
inhibition. What then could be the possible upstream activator of the dimer form of
ATM? Upstream activation ofPI3K-like family members such as PI3K and mTOR can
be mediated by small GTPases (Long et aI., 2005; Aspuria et aI., 2007). The amino acidmediated activation ofmTOR is thought to be mediated by the small GTPase, Rheb
(lnoki et aI., 2005; Long et aI., 2005). Rheb is ubiquitously expressed in all tissues, but
particularly enriched in the brain (lnoki et aI., 2005). Indeed, it is the brain enrichment
that is its namesake: Ras homolog enriched in brain. The Rheb interaction with mTOR
has linked it to S6K and 4EBPI activation (lnoki et aI., 2005). Interestingly, this GTPase
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has been further shown to interact with ATM (lnoki et aI., 2005). Though the function of
this interaction is not known, such a discovery offers an attractive activation mechanism
possibility for ATM-regulated nucleolar transcription. As Rheb has already been
identified in activating mTOR in response to nutrient presence and inducing S6K and
4EBP1 activation (lnoki et aI., 2005; Long et aI., 2005), it is conceivable that Rheb could
activate ATM to stimulate nucleolar transcription in response to cellular need. A
potential problem with this hypothesis is that Rheb is cytoplasmic - activated by the
GTPase activating protein (GAP), TSC2, whereas ATM is enriched in the nucleolus, near
its transcriptional target. Though conceivable that Rheb could shuttle to the nucleolus,
another GTPase, Nog1, resides in the nucleolus and regulates rRNA maturation (Park et
aI., 2001; Lapik et aI., 2007). Though there is no evidence of interaction with ATM,
Nog1 complex formation has been shown to be regulated by mTOR and function in the
nucleolus to mediate late ribosomal maturation (Honma et aI., 2006). These findings
provide enough circumstantial evidence to warrant further investigation ofNogl or Rheb
as an upstream activator of ATM-mediated nucleolar transcription.
The nucleolar ATM target to induce Poll-mediated transcription is currently
unknown. A search of phosphorylation sites on nucleolar transcriptional machinery
offers possibilities that include NPMIB23 (Li et aI., 2007; Nalabothula et aI., 2010), and a
proteomics report of an undescribed interaction between SIRT7 and ATM (Tsai et aI.,
2011), while others have reported irradiation-mediated phosphorylation ofTAF1C, and
TTF1 by ATM (Matsuoka et aI., 2007). TAF1C is a component ofSLl/TIF-1B, involved
in regulating the interaction between Poll and the rDNA promoter and required for
transcriptional elongation (Anney et a!., 2010; Drygin et a!., 2010). The other potential
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ATM targets (TTFI, NPMlB23 and SIRT7) may be intimately related to the regulation of
Poll-mediated by ATM. NPMlB23 is a particularly attractive choice as its histone
chaperone activity has been identified to enhance Poll-mediated transcription by binding
to the chromatin surrounding the rDNA promoter (Murano et aI., 2008). Further, the
NPMlB23 SI25 residue has been identified as an ATMlATRJSMG phosphorylation site

(Maiguel et aI., 2004; Nalabothula et aI., 2010). In addition, the abundance ofNPMlB23
is directly proportional to the rate of transcription, perhaps to maintain the euchromatin
structure (Murano et aI., 2008). Evidence suggests that NPMlB23 is upregulated in ATM
deficient cells (Nalabothula et aI., 2010), the reasons for which are not yet entirely clear
(Colombo et aI., 2011). A simple explanation for this observation could be that because
p53 is increased in ATM-deficient cells (Kamijo et aI., 1999), the increased expression of
NPMlB23 is a response to negatively regulate p53 stabilization (Nalabothula et aI.,

2010).
Additional ATM targets include TTFI and SIRT7. TTFI is one target potentially
intimately related to NPM/B23. NPMlB23 is used as a chaperone to shuttle a nucleolar
localization sequence-bound TTFI from the nUcleoplasm to the nucleolus to initiate
rDNA transcription. In contrast, ARF prevents TTFI from accumulating in the nucleolus
by blocking the nucleolar localization sequence, thereby preventing rDNA transcription
(Lessard et aI., 2010). A recent proteomics study identified an interaction between ATM
and SIRT7 (Tsai et aI., 2011). This interaction was presented in a supplemental data list
of proteins that showed positive interaction with SIRT7. However, SIRT7 has been
shown to interact with UBF and is necessary for sufficient Poll transcriptional activity
(Ford et aI., 2006; Grob et aI., 2009) by its promotion of chromatin remodeling (Tsai et
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aI., 2011). Perhaps the chromatin remodeling function of SIRT7 activates ATM, which
subsequently phosphorylates NPM either to initiate TTFI nucleolar localization, or as
part of a previously unidentified initiation complex.
Whatever the upstream activator and nucleolar target is, the nucleolar enrichment
of ATM may be functionally important. Among its other functions, ATM can be
included as a growth-stimulating kinase (Yang and Kastan, 2000; Li and Yang, 2010).
Adding ATM to the other pathways that positively regulate rDNA transcription provides
further layer of regulation of an extremely important process. What about ATM favored
its contribution to this redundant activity? During evolution, did the primary functions of
ATM include Poll regulation as may be indicated by its nucleolar enrichment? Can
ATM as SMG-l (also known as ATX) respond to damage and or secondary structures in
RNA and if so, could rRNA processing activate an ATM -dependent auto feedback loop
that drives Poll? These are all intriguing questions that if answered may provide
additional information about this novel positive regulator of nucleolar transcription.

Consequences of nucleolar dysfunction
Dysfunctional ribosomal biogenesis has an obvious consequence: ribosomal
renewal will be halted or insufficient. If ribosomal renewal is necessary for the sufficient
translation of genes, then its impairment will negatively impact cellular maintenance
(Bramham and Wells, 2007; Besse and Ephrussi, 2008). Growth will be impaired
(Grummt, 2010), as will be the re-initiation of the cell cycle (Drygin et aI., 2010). In
postmitotic neurons, dendritic arborization and outgrowth, as well as axon guidance and
local protein synthesis will be negatively impacted with dysfunctional ribosome synthesis
(Alvarez et aI., 2000; Cox et aI., 2008; Gomes et aI., 2011), resulting in the impaired
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communication between the nucleus and distant synapses. Further, protein synthesisdependent forms of synaptic plasticity such as LTP would be impaired (Ostroff et ai.,
2002; Malenka, 2003).
Yet implied in the singular impairment of ribosomal biogenesis are other
consequences not related to protein synthesis. Impaired rDNA transcription disrupts
nucleolar integrity allowing nucleolar proteins to diffuse into the nucleoplasm and allow
the accumulation ofp53, which can cause apoptosis (Olson, 2004; Boulon et ai., 2010).
Further, the reorganization of the nucleolus following mitotic nucleolar disruption is
brought on by CDC14B, a phosphatase that reactivates SLl/TIF-lB after mitosis in
cycling cells (Drygin et ai., 2010). Without the cooperation of a Cdk4-cyclin D/Cdk2cyclin EI A-mediated active UBF in early G I-phase, however, Poll-mediated
transcription, would not be optimized. The post-mitotic reorganization process, like
stress-induced nucleolar disruption, requires multiple steps that could be dysregulated if
cellular stress caused the disruption (Angelier et ai., 2005; Boulon et ai., 2010;
Hernandez-Verdun, 2011). Disassembly of the nucleolus in prophase includes the
phosphorylation ofNPMlB23 by Cdkl-cyclin B to reduce its RNA-binding affinity.
During anaphase RNA binding affinity is restored by the phosphatase, PPI (Negi and
Olson, 2006; Hernandez-Verdun, 2011). Interestingly, in ATM deficient cells, PPI
dephosphorylation ofNPMlB23 is dysregulated, thus allowing for the overexpression of
NPMlB23, as well as its increased expression, and increased phosphorylation ofS125,
leading to reduced p53 degradation (Tang et ai., 2008; Nalabothula et ai., 2010). This
same phosphorylation site is an interphase casein kinase 2 (CK2) phosphorylation site
that regulates the interaction ofNPMlB23 with other nucleolar proteins during nucleolar
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re-assembly thereby contributing to the rate at which the nucleolus assembles during
telophase (Negi and Olson, 2006). This may suggest that in ATM deficient cells where
p53 accumulation is increased (Kamijo et aI., 1999) there is also a reduced reassembly of
the nucleolus in telophase compared to wildtype cells, as the phosphorylation-mediated
assembly could be mediated by changes in dissociation constants. In addition, if a
stressful stimuli induces NPMlB23 translocation from the nucleoplasm, this may suggest
that NPM/B23 or its upstream activator, Cdk1, is a substrate of stress-induced JNK2,
which regulates the nucleolar stress response. The stress-induced phosphorylation by
JNK2 on TIF-IA at T200 impairs the interaction between SLl/TIF-lB and Poll thereby
preventing the initiation complex from forming on the rDNA promoter. Indeed,

NPMlB23 translocation is also dependent upon JNK2 in response to UV exposure
(Yogev et aI., 2008). These findings suggest that the phosphorylation status ofNPM/B23
may regulate the rate at which the nucleolus can be assembled and disassembled, thus
mutations ofNPMlB23 could have profound effects on the function and presence of the
nucleolus. A recent discovery has identified the intergenic spacer regions of rDNA as a
generator of stress-specific, inducible, large non-coding RNAs (IncRNA) that regulate the
passive diffusion of specific proteins between the nucleolus and nucleoplasm. The
IncRNAs capture proteins that display a peptidic code termed the nucleolar detection
sequence (NoDS) and keep them in the nucleolus (Audas et aI., 2012). This new
mechanism adds yet another layer of complexity to the nucleolar stress response and
begins to mechanistically explain the specific diffusion of proteins under specific
stresses.
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In postmitotic neurons, genotoxic stress by topoisomerase I or II poisons impairs
nucleolar transcription and causes p53-mediated apoptosis in neonates. If the exposure to
a nucleolar-sensitive genotoxic stressor is sublethal and transient, there is evidence to
suggest that the nucleolar response is transient also (Zhang et aI., 1988; Casafont et aI.,
2011). Indeed, within 1 day ofIR-induced DNA damage to sensory ganglion neurons,
nucleolar transcriptional activity resumes (Casafont et aI., 2011). This suggests that the
neuronal nucleolar transcription suppression we observed in etoposide-treated rats would
likely have resumed had it been evaluated 1 day post treatment. Indeed, at least in rat
neonates, we observed the resumption of an intact nucleolus as identified by the nucleolar
presence of B23 immunostaining at 72 h post ICV etoposide delivery. Therefore,
transient inhibition of nucleolar transcription may not induce long-term neuronal damage
in the mature nervous system. Support for this notion comes from human neurotoxicity
studies of chemotherapy agents, such as etoposide. For instance, the neurological side
effects are relatively infrequent and short lasting following etoposide delivery through the
intracarotid artery to treat brain tumors (Madajewicz et aI., 2000). The few ill effects
noted include headache, focal seizure, blurred vision, and, most commonly, transient
confusion. This latter effect was reported in only 8 of 168 treated individuals (Tfayli et
aI., 1999; Madajewicz et aI., 2000). In addition, a long-term animal study evaluated
cognitive impairment following 18-week long regiments of chemotherapy delivered by
five systemic injections every four weeks (Lee et aI., 2006). One of the chosen drugs, 5FU, is known to cause nucleolar stress (Rubbi and Milner, 2003). Surprisingly, after a 7week recovery, LTP was enhanced, but subsequently returned to control levels at 42
weeks. It is tempting to speculate that the initial enhancement of LTP was due to highly
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active ribosomal biogenesis during the rebound phase following its inhibition during
chemotherapy. This increased rate of ribosomal renewal may have replaced numerous
damaged ribosomes with impaired function. With increased numbers of functioning
ribosomes, local protein synthesis may have been enhanced and successful
communication between the nucleus and synapses enhanced. Further, increased
accumulation ofp53 in the nucleus following nucleolar disruption is likely to have
ceased, and along with it the ceasing of enhanced stress-mediated responses. Therefore,
if in the mature nervous system the impairment of Poll-mediated transcription is
transient, it may produce no residual neuronal deficits (Fig. 17). To be certain, more
work is required to quantify the cellular recovery rate by genotoxin type, delivery and
dose, as well as by recovery period and age at treatment. Indeed, reports of chemobrain,
also termed chemotherapy-induced cognitive impairment, are most commonly associated
with treatments of breast cancer, but remain elusive as to the triggers, treatment
conditions that potentiate it, and duration (Kannarkat et aI., 2007; Whitney et aI., 2008;
Argyriou et aI., 2010; Mitchell and Turton, 2011). Though the frequency of associations
are ever increasing, little is understood about the susceptibility of patients to chemobrain.
This is partially due to the primarily descriptive and associative nature of chemobrain
reports, but also confounded by the variation in ages of chemotherapy onset and post
treatment longevity (Argyriou et aI., 2010).
The effects of genotoxic stress on postmitotic neurons could be compounded by
age as they are postmitotic and dependent on translation for cellular maintenance and
synaptic plasticity. Therefore, it may be anticipated that progressive, impaired ribosomal
biogenesis could result in dysfunction or neurodegeneration. Indeed, the repetitive nature
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of the rDNA tandem repeats increases the susceptibility of rDNA to recombination, and
has been associated with regulating senescence in yeast (Kobayashi, 2011). Moreover,
mammalian age-related rDNA gene loss were described in the early 1970s (Johnson and
Strehler, 1972), suggesting that impaired ribosomal biogenesis is a consequence of
natural aging. Further, age-related loss of rDNA has been observed in the human cerebral
cortex (Strehler et aI., 1979), and 5S and 28S rRNA genes have been shown to be
preferentially lost in human adipose tissue during natural aging (Zafiropoulos et aI.,
2005). Interestingly, rDNA loci were increased in the parietal and prefrontal cortex of
postmortem Alzheimer's Disease patients, compared to age-matched controls, as was
cytosine methylation at the rDNA promoter (Pietrzak et aI., 20lla). This could be
explained by increased stability of silenced, hypermethylated rDNA. Indeed, increased
cytosine methylation has been shown to stabilize yeast rRNA genes (Kennedy et aI.,
1997). Further, prematurely senescent primary fibroblasts from human Werner syndrome
(WS), a progeroid disorder, did not display any locus instability, but showed increased
cytosine methylation within rRNA genes (Machwe et aI., 2000).
The DNA damage repair pathway, nucleotide excision repair (NER), has recently
been associated with rDNA transcription (Assfalg et aI., 2011). Mutations ofTFIIH
subunits associated with Cockayne syndrome impair rDNA transcription. The authors
indicate that TFIIH, a general transcription factor of RNA Polymerase II, is essential for
rDNA promoter occupancy and Poll-mediated transcriptional elongation. Indeed, these
findings suggest that the progeroid disorder, Cockayne syndrome, and perhaps other
mutations ofNER that cause progeria and cancer predisposition have associations with
impaired ribosomal biogenesis.
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Recent years have brought growing evidence for an association between reduced
ribosomal biogenesis and neurodegenerative diseases. Tamoxifen-induced ablation of
Tif-la in the mature CNS potentiates noticeable cell loss in the dentate gyrus and CA
regions of the hippocampus beginning at one month post tamoxifen treatment (Parlato et
aI., 2008). The ablation ofTif-la in mature mouse dopaminergic neurons leads to
reduced cell number and a Parkinsonian phenotype that can be rescued by L-Dopa
administration (Rieker et aI., 2011). Indeed, translocation ofNPMlB23 from the
nucleolus to the nucleoplasm and decreased visibility of nucleoli has been observed in
dopaminergic neurons of postmortem Parkison's patients (Rieker et aI., 2011). In the
CAG expanded repeat disorder, Huntington's Disease (HD), dysfunctional UBF
acetylation impairs UBF occupancy on the rDNA promoter in a mouse model ofHD. In
addition, these authors observed reduced UBF protein levels in human postmortem
striatum (Lee et aI., 2011). In Alzheimer's Disease (AD), the presence of decreased
polyribosomal function has been described in the postmortem parietal cortex (Ding et aI.,
2005). The ribosomal dysfunction is at least partially associated with increased rRNA
oxidation (Ding et aI., 2006). Further, increased rRNA oxidation by iron binding has
been identified in the AD postmortem hippocampal cytoplasm. Moreover, AD associated
oxidative damage resulted in 8-hydroxyguanosine insults, which were not witnessed in
age-matched controls (Honda et aI., 2005). There has also been neuronal nucleolar
atrophy, a symptom of reduced Poll-mediated transcriptional activity, identified in AD
postmortem hippocampi and cerebral cortices (Tagliavini and Pilleri, 1983; Mann et aI.,
1988; Iacono et aI., 2008). In addition, Prader-Willi Syndrome (PWS) patients and
mouse models ofPWS have recently been shown to have atrophic Purkinje cell nucleoli
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(Leung et al., 2009). Interestingly, published electron micrographs may suggest the
absence of nucleoli in Purkinje cells of Atm-/- mice, indicating that the cerebellar
neurodegeneration associated with ATM deficiency may be associated with nucleolar
disruption (Kuljis et al., 1997). Further, deficiency of ATM results in increased
accumulation of iron and subsequent increased accumulation of oxidative stress
(McDonald et al., 2011). Thus, the absence of ATM may potentiate the rRNA-targeted
oxidative stress and ribosomal dysfunction. These findings are particularly interesting in
light of results presented herein pertaining to the regulation of Poll transcription by
ATM, as it suggests that long-term (i.e., life-time of the animal) insufficient ribosomal
biogenesis may cause a permanent collapse of nucleoli leading to cellular degeneration.
Therefore, the renewal of neuronal ribosomes may be necessary to prevent consequences
of oxidative stress including ribosomal failure. Conversely, chronic nucleolar
transcriptional impairment may tum rRNA to be an oxidative stress sink. This notion
favors a long accumulation of oxidative insult with pathology evidenced after years,
consistent with many neurodegenerative diseases, including A-T. Importantly, these
nucleolar associations with neurodegenerative disease do not claim to be causative.
Though deletion of Poll transcription (Rieker et al., 2011) is able to cause the symptoms
associated with PD as a proof of principle, the ablation of nucleolar transcription is
unlikely. Therefore, additional work is required to identify biological consequences of
nucleolar insufficiency in neurodegenerative conditions such as A-T.
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The nucleolus as a therapeutic target
The breadth of functions associated with the nucleolus make it an enticing candidate for
targeted therapies. NPM/B23 is an exciting potential therapeutic target because it has the
capability of promoting nucleolar disruption, which could be useful in cancer therapy,
while it also has the potential to promote nucleolar assembly and euchromatin formation.
The phosphorylation ofNPMIB23 can cause disruption of the nucleolus, which, if
targeted and constitutive, would cease tumor growth. Conversely, constitutive
phosphorylation at S 125 may promote rapid reassembly of a disrupted nucle9lus that
could prevent transient or permanent cellular damage. Similarly, as the phosphorylation
of these residues are mediated by Cdks and CK2, respectively, these kinases may offer
further target potential to manipulate the structural status of the nucleolus through
NPMlB23. NPMlB23 has already been shown to be a downstream target of ATM
(Nalabothula et al., 2010), presumably under conditions of cellular stress, but it may also
be a target that mediates Poll-mediated transcriptional regulation by ATM.
Constitutively activating NPM/B23 at S125 may rescue insufficient nucleolar
transcription in ATM deficient cells. Indeed the number of protein-protein interactions
with ATM in the nucleolus is regularly increasing. SIRT7 is one such newly discovered
ATM-interacting protein (Tsai et al., 2011) that has been shown to be essential for
nucleolar transcription (Ford et al., 2006; Grob et al., 2009). Thus, SIRT7 may be another
target of ATM to promote nucleolar transcription. Though SIRT7 has been shown to
have very limited deacetylase activity (Tsai et al., 2011), it is required for Poll
transcription (Grob et al., 2009). Given the attention paid to sirtuins in the pharmaceutical
industry, this target may be a low-hanging fruit.
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Components of the Poll initiation complex are convenient targets for potential
therapies as well, with potentially numerous substrates that affect transcriptional
initiation and elongation. Indeed, constitutively active TIF-IA has been effective way to
selectively stimulate Poll under numerous conditions (Grummt, 2010; Gomes et aI.,
2011). Many groups have already attempted to target the phosphatase CDCI4B for its
dephosphorylation ofSLl/TIF-IB to reset the Poll initiation complex after mitosis
(Mocciaro and Schiebel, 20 I 0). This phosphatase remains an interesting target, as does
SLl/TIF -I B in the field of cancer, as tumorigenesis would presumably not resume if
CDCI4B were unable to reactivate SLl/TIF-IB. However, overexpression ofCDCI4B
is now thought to be oncogenic, suggesting multiple functionality of this phosphatase
(Wei and Zhang, 2011). UBF has been identified in HD patients as being poorly
expressed, thus therapies that may increase its expression and interactions with the rDNA
promoter and Poll initiation complex may prove beneficial.
Given the recent associations between nucleolar dysfunction and disease there is
hope that therapeutic interventions targeting the nucleolus will emerge. Indeed the
plurifunctionality of the nucleolus is becoming more and more evident. Therefore, I
speculate that the list of genes that regulate nucleolar function and are associated with
diseases will only become longer, thus prompting more development efforts towards
therapies that target the nucleolus.
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Figure 17. Chronic nucleolar transcriptional impairment leads to
neurodegeneration
Sustained Poll-mediated transcriptional inhibition by either persistent genotoxic insult or
ATM deficiency leads to decreased sufficiency of protein synthesis. The persistence of
these events may lead to neurodegeneration.
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